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Clathrin-mediated endocytosis (CME) is key to main-
taining the transmembrane protein composition of
cells’ limiting membranes. During mammalian CME,
a reversible phosphorylation event occurs on
Thr156 of the m2 subunit of the main endocytic cla-
thrin adaptor, AP2. We show that this phosphoryla-
tion event starts during clathrin-coated pit (CCP)
initiation and increases throughout CCP lifetime.
m2Thr156 phosphorylation favors a new, cargo-
bound conformation of AP2 and simultaneously
creates a binding platform for the endocytic NECAP
proteins but without significantly altering AP2’s
cargo affinity in vitro. We describe the structural
bases of both. NECAP arrival at CCPs parallels that
of clathrin and increases with m2Thr156 phosphory-
lation. In turn, NECAP recruits drivers of late stages
of CCP formation, including SNX9, via a site distinct
from where NECAP binds AP2. Disruption of the
different modules of this phosphorylation-based
temporal regulatory system results in CCP matura-
tion being delayed and/or stalled, hence impairing
global rates of CME.
INTRODUCTION
The levels of a vast array of transmembrane proteins of widely
differing functions must be tightly but dynamically regulated.
This is achieved by controlling the rate of each protein’s internal-
ization, which occurs mainly by clathrin-mediated endocytosis
(CME) and balancing it with its rates of delivery to the surface
after biosynthesis, transport down the endocytic system, and re-
cycling back to the cell surface. CME is mediated by clathrin-
coated vesicles (CCVs) that matured from clathrin-coated pits494 Developmental Cell 50, 494–508, August 19, 2019 ª 2019 The A
This is an open access article under the CC BY license (http://creative(CCPs). The most abundant proteins in endocytic CCVs are cla-
thrin itself, which forms the outer polyhedral scaffold, and the
clathrin adaptors AP2 and clathrin assembly lymphoid myeloid
leukemia protein (CALM), which couple the clathrin layer to the
inner membrane. Lower levels of other clathrin adaptors and
CME accessory proteins are also found in the central layer
(Borner et al., 2012; Kirchhausen et al., 2014). Other proteins
that can be localized to CCPs are found in vanishingly small
quantities in intact CCVs (Borner et al., 2012).
Early biochemical studies, supported by more recent live-cell
imaging and cryo-electron tomography studies (Heuser, 1980;
Kukulski et al., 2012), have resulted in a model for coat formation
of single, isolated, CCVs, (reviewed in Lampe et al., 2016; Met-
tlen et al., 2018) in which formation proceeds in an ordered, step-
wise manner: initiation at a site enriched in PtdIns4,5P2 by AP2
aided by Fcho1/2 and Eps15/R that can be stabilized by clathrin
recruitment, followed by expansion of a clathrin-coated struc-
ture through recruitment of more cargo-bound clathrin adaptors
and clathrin, and finally coat andmembrane deformation. Similar
CCVs can also be formed from the periphery of large, flat pre-ex-
isting clathrin ‘‘plaques’’ in an analogous manner (Lampe et al.,
2016). In either case, deformation continues to form a ‘‘necked’’
structure that undergoes scission and then finally uncoating (re-
viewed in Antonny et al., 2016; Mettlen et al., 2018).
Reversible protein phosphorylation is a common mechanism
for controlling cellular processes (Nishi et al., 2011). Themultiplic-
ity of kinases and phosphatases, whose activity can be regulated
in a wide number of ways including by phosphorylation itself,
allows this mode of regulation to be finely tuned with exquisite
temporal and spatial precision and also to be arranged in ampli-
fication cascades and feedback loops. Protein phosphorylation
often exerts regulation through driving conformational changes,
creating binding determinants for positively charged moieties,
and/or repelling poly-anionic species such as the negatively
charged phospholipid-rich membranes, as demonstrated by
the neuronal dephosphins (Cousin and Robinson, 2001).
The 300 kDa heterotetrameric AP2 complex (a, b2, m2, and s2
subunits) (Figure S1A) is essential for CCV formation. Binding touthors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
PtdIns4,5P2 causes recruitment of AP2 to the plasma mem-
brane, which induces a conformational change from its closed
cytosolic form (Collins et al., 2002), resulting in activation of
two key functions: binding of the two most common transmem-
brane protein endocytic cargo-sorting signals (YxxF and [ED]
xxxLL) and binding to clathrin (Jackson et al., 2010; Kelly et al.,
2008; Owen and Evans, 1998). Thus, clathrin polymerization
and coat formation are coupled to cargo capture (Kadlecova
et al., 2017; Kelly et al., 2014).
AP2 is subject to multiple phosphorylation events (Conner
and Schmid, 2002; Olusanya et al., 2001; Pauloin et al., 1982;
Pauloin and Thurieau, 1993; Wilde and Brodsky, 1996). The
best characterized and most prominent site of phosphorylation
in AP2 is T156 in the linker between the two domains of m2 (Ho¨n-
ing et al., 2005; Olusanya et al., 2001; Pauloin and Thurieau,
1993; Smythe and Ayscough, 2003). The effects of mutation
of m2T156 in vivo combined with biophysical studies from our
laboratories suggested that phosphorylation was required for
cargo capture via a phosphorylation-induced conformational
change that facilitates cargo and membrane binding. However,
this hypothesis is based largely on in vitro studies, and it con-
flicts with aspects of temporal ordering in CCV formation. For
instance, phosphorylation of m2T156 by a Numb-associated
kinase (NAK) family member, either a-adaptin associated kinase
(AAK1) or potentially BIKE (aka BMP2K) (Borner et al., 2012;
Sorrell et al., 2016), is thought to be activated by clathrin binding
(Conner and Schmid, 2002; Jackson et al., 2003; Olusanya
et al., 2001; Ricotta et al., 2002; Sorrell et al., 2016). Conse-
quently, m2 phosphorylation should only occur after some cla-
thrin polymerization on AP2 has already happened, and this in
turn will only have occurred when AP2 has already bound mem-
brane and cargo and so undergone its conformational change
(Jackson et al., 2010; Kelly et al., 2014).
To unravel the functional significance of m2 phosphorylation,
we applied an array of complementary approaches: quantitative
immunofluorescence was used to localize phosphorylated AP2
to CCPs; X-ray crystallography to determine a new open confor-
mation adopted by phosphorylated AP2 (termed P-AP2 from
now on); surface plasmon resonance (SPR) to measure the affin-
ity of AP2 and P-AP2 to endocytic signals; biochemical and
mass-spectrometry-based analyses to identify and characterize
the phosphorylation-dependent binding of a new m2 interaction
partner, NECAP; and structural NMR analysis to characterize
this interaction at the molecular level. Finally, highly specific
NAK kinase inhibitors were used in combination with high tem-
poral resolution, multi-color, live-cell imaging to show that AP2
phosphorylation is required for efficient NECAP recruitment to
CCPs and the maturation of productive CCVs.
RESULTS
Molecular Perturbations of AP2 m2 Phosphorylation in
RPE Cells
The specific localization and even the partitioning between
cytosol and membrane fractions of P-AP2 in unperturbed cells
has long been controversial, although it was recently shown
that AP2, rendered cytosolic by mutation of its PtdIns4,5P2 bind-
ing site, showed markedly reduced levels of m2 phosphorylation
(Kadlecova et al., 2017). Here, we use an antibody that only rec-ognizes m2T156 when it is phosphorylated (Figure S1B andman-
ufacturer’s information). Immunofluorescence microscopy of
retinal pigment epithelium cells (RPE) cells shows that P-AP2 is
present in themajority (70%) of AP2-positive CCPs (Figure 1A).
Small-molecule inhibitors allow for acute inhibition of kinase
activity and hence minimize compensatory pathways that may
obscure the actual function of phosphorylation events. LP-
935509 (subsequently LP) is a recently evolved potent (low nM
IC50) inhibitor of the m2-phosphorylating NAK family members
in human AAK1 and BIKE, which binds in their structurally similar
ATP-bindingpockets (Kostich et al., 2016;Sorrell et al., 2016).We
used LP and also a previously tested structurally different inhibi-
tor (INHIB2 CAS 1093222-27-5) (Bamborough et al., 2008) to
analyze the dependence of CCP formation and rates of CME on
AP2 phosphorylation in RPE cells. Treatment with either inhibitor
for 3 h effectively decreased AP2 phosphorylation by80% (Fig-
ure S1B). As LP iswell characterized and since it has very few off-
target effects (Kostich et al., 2016), LP alone was used in all
subsequent experiments. We also established a mutant RPE
cell line, expressing an AP2 m2-subunit in which the consensus
substrate recognition sequence was mutated at its key 2 (Q to
S) and +1 (G to A) positions (termed AP2m2NAK) (Smythe and
Ayscough, 2003). Use of AP2m2NAK allowed us to completely
ablate AP2 phosphorylation while maintaining physicochemical
and biochemical properties of T156 (Figures S1C and S1D).
Next, we assessed the dependency of CME rates on AP2
phosphorylation by following transferrin receptor (TfR) internali-
zation: its rate decreased by approximately 30% in both inhibi-
tor-treated cells and also in m2NAK cells (Figures 1B and S1D).
m2NAK cells incubated with the inhibitor LP showed no further
decrease of TfR internalization efficiency as compared with un-
treated m2NAK cells (Figure S1F), indicating that the phenotype
elicited by NAK kinase inhibitors can be attributed to the loss
of m2T156 phosphorylation and not to an off-target effect of
inhibitors.
The Quantity of P-AP2 in CCPs Positively Correlates
with CCP Growth
Using quantitative immunofluorescence microscopy, we first
analyzed global distribution of total AP2 and P-AP2 in CCPs
and calculated the proportion of CCPs that contain AP2 and
P-AP2. We plotted these values as a function of the respective
EGFP-CLCa intensities in the detections (Figure 1C). In control
cells, the proportion of detections positive for P-AP2 increases
linearly with the quantity of EGFP-CLCa. CCPs that contain
P-AP2 are fewer than the CCPs that contain AP2 for any cohort
with a given EGFP-CLCa intensity. Inhibition of NAK kinases with
LP reduces the number of CCPs that contain P-AP2 by at least
3-fold in all clathrin-intensity cohorts (Figure S1G). Assuming
that EGFP-CLCa intensity at CCPs increases during the growth
phase of a CCP (Loerke et al., 2011), our results suggest that
AP2 phosphorylation occurs at the plasma membrane and its
quantity increases with CCP age.
The correlation analysis of paired fluorescence intensity values
between P-AP2, AP2, and EGFP-CLCa reveals that the quantity
of P-AP2 and EGFP-CLCa and the quantity of P-AP2 and total
AP2 are positively correlated in CCPs. In comparison, the corre-
lation between the quantity of AP2 and EGFP-CLCa is even
higher (Figure 1D). These data indicate that the quantity ofDevelopmental Cell 50, 494–508, August 19, 2019 495
Figure 1. m2T156 Phosphorylation Increases as CCPs Mature and Is Important for Efficient CME
(A) Representative images of control RPE cells and cells treated with LP. White arrows indicate the presence of a fluorescent signal in the green channel (EGFP-
CLCa) and the same position in the AP2 (red) and P-AP2 channel (cyan) to compare presence or absence of the corresponding signal at the same position. Scale
bar, 5 mm.
(B) Time course of TfR internalization at 37C. Data represent mean SD, n = 3. Two-tailed unpaired t tests were used to assess statistical significance. *p% 0.05.
(C) Bar graphs represent the quantification of the membrane distribution of AP2 (red) or P-AP2 (blue) in CCPs. The bar height displays the proportion of CCPs
(detected in the EGFP-CLCa channel) that contain significant AP2 or P-AP2 signal in the same position plotted as a function of EGFP-CLCa signal (x axis). Data
represent mean values, n = 30.
(D) Comparison of PCCs to assess the relationship of the paired intensity values of CCP components EGFP-CLCa, AP2, and P-AP2. Data represent mean SD,
n = 30. Two-tailed unpaired t tests were used to assess statistical significance. ****p% 0.0001; ns, p > 0.05.
(E) Representative images of control cells and cells treated with LP, showing the distribution of EGFP-CLCa signal and TfR detected with anti-TfR mAb. White
arrows indicate the presence of the signal in the green channel (EGFP-CLCa) and the same position in the TfR channel. Scale bar, 5 mm.
(F) PCCs comparing the strength of linear relationship of the paired intensity values of EGFP-CLCa and TfR. Bars represent mean SD, n = 27. Two-tailed unpaired
t tests were used to assess statistical significance. ****p% 0.0001.
(G) Representative TIRFM images of control cells and cells treated with LP. Red highlights indicate clathrin-coated structures categorized as persistent. Scale
bar, 5 mm.
(H and I) Scatterplots with the values of density of the persistent structures (H) and the average lifetime of the 95th percentile (I) for control cells, cells treated with
LP, and m2NAK RPE cells. Lines represent mean and SD for each group (n = 20). Two-tailed unpaired t tests were used to assess statistical significance.
****p% 0.0001.P-AP2 in a CCP is influenced by a factor other than the quantity
of AP2 and EGFP-CLCa. We speculate that it reflects the regu-
lated activity and quantity of NAK in CCPs. The correlation be-
tween the total quantity of AP2 and EGFP-CLCa was indepen-
dent of the quantity of m2T156 phosphorylation. These data
suggest that m2T156 phosphorylation is unlikely to directly affect
the interactions of AP2 with either the plasma membrane or cla-
thrin. Further, these data indicate another role for AP2 phosphor-496 Developmental Cell 50, 494–508, August 19, 2019ylation in CCP formation. As expected, the correlation between
P-AP2 and AP2 and between P-AP2 and EGFP-CLCa dropped
by 3-fold upon inhibition of m2T156 phosphorylation with LP
(Figure 1D).
Previous studies used several different experimental systems
to test the role of AP2 phosphorylation in cargo recruitment
to CCPs and yielded conflicting results (reviewed in Smythe
and Ayscough, 2003). Figures 1E and 1F show that the
Figure 2. A New Open+ Conformation for
Cargo-Bound AP2 in Both m2t156 Phosphor-
ylated and Unphosphorylated Forms
(A) Structure of T156-phosphorylated AP2 core
(Pcore) in open+ conformation with YxxF cargo in
gold and dileucine cargo in orange. The refined
2mFo-DFc electron density map (gray) is con-
toured at 1 sigma.
(B–E) Enlargements of functionally important
regions with subunits and refined 2mFo-DFc
electron density colored as above: (B) shows
unambiguous Cm2 positioning, (C) the missing
portion of the phosphorylated m2 linker, (D) YxxF
cargo peptide (2mFo-DFc map clipped to 3A˚
around peptide, contoured at 1 sigma), and (E)
dileucine cargo peptide (2mFo-DFc map clipped
to 3A˚ around peptide, contoured at 0.5 sigma).proportion of CCPs that are TfR positive is not affected by the
phosphorylation status of m2T156, while the accumulation of
TfR in CCPs decreases by only 20% if the NAK activity is ablated
(Figure 1F).
Phosphorylation of AP2 Is Necessary for Efficient
Maturation of CCPs
We used quantitative live-cell total internal reflection fluores-
cencemicroscopy (TIRFM) to investigate which stage of CCP as-
sembly fails in the absence of phosphorylation and compared
CCP assembly rates in inhibitor-treated cells and control cells.
Inhibition of m2T156 phosphorylation resulted in a 10-fold in-
crease in the density of diffraction-limited clathrin-coated struc-
tures that failed to pinch off during the 10-min video acquisition
time (persistent structures) (Figures 1G and 1H). We also
observed that the population of CCPs that underwent scission
displayed extended lifetimes (Figures 1I and S1H).DevelopmeIn sum, these data indicate that m2T156
phosphorylation affects CCP maturation
and the rate of CME but not likely due
to alterations in the efficiency of cargo
sequestration.
Structures of m2T156-P-AP2 Core
Recombinant T156-phosphorylated AP2
core (Pcore) with >95% stoichiometrically
phosphorylated T156 was produced as in
Ho¨ninget al., 2005. Initially,wedetermined
thestructureofPcore in theclosed inactive
form at an 2.8-A˚ resolution in complex
with the PtdIns4,5P2 analog IP6 bymolec-
ular replacement using the closed struc-
ture (PDB 2VGL) as a search model (Table
S1). The structure did not differ from that of
the unphosphorylated AP2 (core) (root-
mean-square deviation [RMSD] of 0.56 A˚
over 1,717 residues). No electron density
for the phosphorylated m2 linker was
visible, suggesting that it does not bind
back onto the rest of the core and that it
is staticallyand/ordynamicallydisordered.Despite extensive efforts, we were unable to crystallize Pcore
in the presence of the TGN38 YxxF cargo peptide DYQRLN in
any conditions, including those that led to the determination of
the initial open structure where the myc tag of an adjacent AP2
takes the place of an [ED]xxxLL cargo motif (Jackson et al.,
2010). However, in the presence of both DYQRLN and RM(pS)
QIKRLLSE, crystals were obtained that diffracted to an apparent
resolution of 3.4 A˚ with an anisotropic deltaB of 1.6. The structure
was solved by two-stagemolecular replacement with Phaser us-
ing first the ‘‘bowl’’ (a and b2 solenoids, Nm2, and s2) of the open
form (PDB 2XA7) and subsequently Cm2 from the same structure
(McCoy, 2007; Winn et al., 2011), and as with all previous AP2
structures, some regions are considerably better ordered than
others.
The structure is clearly in a new active and open conformation
that we term open+ (Table S1; Figures 2A–2C and S2A): the bowl
superimposes well (RMSD of 1.3A˚ over 1,353 residues) with thatntal Cell 50, 494–508, August 19, 2019 497
Figure 3. TheOpen+ Conformation Is Related to the Open Conformation byMovement of m2 and IsMembrane- or Cargo-Binding Competent
(A) Views ‘‘perpendicular to’’ (top row) and ‘‘through’’ (bottom row) the membrane of Pcore in ‘‘closed’’ or ‘‘locked’’ cytosolic conformation (left column) and
membrane attached open (center) and open+ (right column) conformations.
(B) Relative positions of Cm2 in closed (orange), open (blue), and open+ (purple) conformations of Pcore aligned by the superposition of their a subunits.
(C) Superposition of entire m2 subunits in open (gray) and open+ conformations, superimposed on the basis of Nm2 to highlight the change in orientation of the two
subdomains relative to each other viewed ‘‘through the membrane.’’ Modeled fragments of linkers are shown as dashed.of the open form, and the hollow of the bowl is not occupied by
Cm2, as it is in the closed conformation (Figures S2A–S2C). Both
cargo peptides are clearly bound (Figures 2D–2E and S2B–S2D),
although the electron density would suggest the [ED]xxxL[LI]
binding site is not fully occupied. The main difference with the
open conformer (PDB 2XA7) is that Cm2 is in a different orienta-
tion, rotated by90 and translated by9A˚ with respect to N-m2498 Developmental Cell 50, 494–508, August 19, 2019such that it packs against residues 300–400 of b2, burying a
solvent accessible surface area of 640A˚2 (Figures 2A, 3B, 3C,
S2A–S2D, and S3A–S3F). There are further differences between
the two conformations; for instance, in the new conformation,
the first four helices of b2 are poorly ordered although present
(see Supplemental Information). The loss of electron density for
these helices can be explained by the breaking of the interface
between the a/s2 and b2/Nm2 heterodimers since in the closed
conformation, a large part of this interface comes from F6 and
Y7 of b2 binding into the dileucine-motif-binding site on s2,
which is now displaced by genuine dileucine cargo. This new
open+ conformation indicates that Cm2 is able to explore the
membrane in its local vicinity to ‘‘hunt’’ for cargowhilst remaining
physically tethered to the membrane-binding bowl through the
m2 linker.
The m2 linker in the open form (2XA7) is mostly ordered with
residues 142–157 adopting a helix. T156 is buried and so inac-
cessible to a kinase and hence should not be phosphorylatable.
Further, a phosphate at this position would also likely cause ste-
ric clashes with b2 and Nm2, which would disfavor an open
conformation for Pcore and explain our inability to crystallize
Pcore in the open conformation. In the new open+ form, there
is no traceable density for the residues 134–158 including the
phosphorylated threonine (Figure 2C) despite using various ap-
proaches (see STAR Methods). N.b., there had been no change
in the percentage of phosphorylated m2T156 as determined by
analysis of Pcore post-data collection (data not shown): these
data suggest that in open+, the m2 linker is likely unstructured,
mobile, and accessible to NAK kinases and T156-phosphate
when present and does not bind back onto AP2 to drive the
conformational change as we and others had suggested (Ho¨ning
et al., 2005; Olusanya et al., 2001).
Crystals with similar morphology and space group dimension
to those of open+ Pcore were also obtained of core, but none dif-
fracted beyond an 6-A˚ resolution. Molecular replacement
clearly showed that the core in this crystal form was in the
open+ conformation (Figures 3A, S3C, and S3D; Table S1): this
was not pursued further. These data suggest, however, that
the open+ conformation is accessible to both core and Pcore
but is likely promoted by m2T156 phosphorylation. Thus, it
is likely that in the cell, unphosphorylated AP2 exists in equilib-
rium between open and open+ (and possibly other) forms (Fig-
ure 3D) with only the open+ form compatible with m2T156
phosphorylation.
m2T156 Phosphorylation Does Not Have a Major Effect
on AP2’s Affinity for Membrane-Embedded Cargo
The open+ structure is compatible with membrane-embedded
cargo binding, although it would need to use some different
lysine residues on Cm2 for PtdIns4,5P2 binding (Figure S2D). In
light of this and the improvements in SPR, we revisited our lipo-
some-based SPR studies (Ho¨ning et al., 2005). The association
phases were too complicated to be modeled; however, the
dissociation phases could be modeled using a double exponen-
tial, corresponding to fast and slow phases (Table S2; Fig-
ure S3G). Binding to PtdIns4,5P2-only membranes is unaffected
by the core phosphorylation state: the fast and slow phases likely
correspond to closed forms associating via one of their two
orthogonal PtdIns4,5P2-binding sites. The presence of cargo in-
creases the apparent strength of AP2 or P-AP2 binding to all
PtdIns4,5P2-containing liposomes, presumably by triggering
the AP2 or P-AP2 to adopt open or open+ conformations. The
fast and slow phases now seen result from AP2 or P-AP2 bound
to PtdIns4,5P2 only and to PtdIns4,5P2 + cargo, respectively,
with the interactions being 5- to 15-fold (fast) and 30- to 100-
fold (slow) stronger than the fast and slow phases seen whencargo is not present. However, there is only a modest (3-fold)
increases in YxxF-containing liposome-binding affinity on core
phosphorylation, likely resulting from phosphorylation stabilizing
the open+-cargo-binding competent core conformation. There
are no obvious differences upon AP2 phosphorylation in binding
the dileucine cargo. In support of this, using fluorescence anisot-
ropy, we show that m2T156 phosphorylation causes no obvious
change in the affinity of AP2 for YxxF cargo peptides, when AP2
is stimulated by the addition of polyanionic heparin to mimic the
presence of a PtdIns4,5P2-enriched membrane (Figure S3H)
(Jackson et al., 2010).
When considered with the effects of treatment with NAK
inhibitors described above, these data suggest that although
phosphorylation of m2T156 is functionally important during endo-
cytosis, it is not through significantly altering the affinity of AP2
for the membrane and its embedded cargo as we and others
had previously suggested. The question thus arises, ‘‘what is
the major role of m2T156 phosphorylation in CME?’’ One obvious
possibility is that m2 phosphorylation could modulate or even be
a prerequisite for binding of other proteins.
m2T156 P-AP2 Cores Bind to NECAP1 and NECAP2
To search for potential Pcore binding partners, we carried out
pull-down experiments from brain lysates using glutathione
S-transferase (GST)-tagged core and Pcore coupled to sephar-
ose beads and mass spectrometry for protein identification. Any
protein with binding to GST and/or core was rigorously filtered
from the data. In the remaining list, NECAP1 and NECAP2
were identified as the two top hits that bound Pcore only (Fig-
ure 4A; Table S3). These data were confirmed in subsequent
pull-down experiments with pure recombinant proteins (Figures
4B, S4C, and S4D), which showed that NECAP1 preferentially
binds Pcore over core. These data are in line with a recent
elegant study in C. elegans (Beacham et al., 2018), published
after our independent identification of NECAP as a direct binding
partner of mammalian P-AP2 had been made.
P-AP2 Binds NECAPs through Its Phosphorylated m2
Linker and a-Appendage
NECAPs consist of an N-terminal, 133-residue PHear domain,
and C-terminal 120–150 residues unstructured region that con-
tains WxxF a-appendage binding motifs (Figures S4A and S4B)
in mammalian but not in C. elegans NECAP orthologs. NECAPs
are known to bind other endocytic proteins containing FxDxF-
like motifs, such as amphiphysin or Bin1 and CALM with KDs in
a range of hundreds of mMas determined in NMR titrations (Ritter
et al., 2007), indirectly influence CCV size via CALM (Miller et al.,
2015; Ritter et al., 2013), and a loss-of-function mutation in
necap1 is a heritable cause of early infantile epileptic encepha-
lopathy (Alazami et al., 2014).
‘‘Pull-downs’’ and isothermal titration microcalorimetry (ITC)
(Figures 4C, 4D, and S4C–S4E) show that the PHear domain
alone binds Pcore but not core in solution with a KD of 8 mM.
In these experiments, the Pcore should be in its closed non-
cargo-binding form (this work and (Jackson et al., 2010)). Using
m2 constructs of various lengths, either unphosphorylated or
phosphorylated by co-expressing them with the AAK1 kinase
domain, we showed that the m2 linker (residues 122–163) is
sufficient for an interaction with NECAP PHear and that theDevelopmental Cell 50, 494–508, August 19, 2019 499
Figure 4. NECAP Binds to AP2 Core
in a m2T156-Phosphorylation-Dependent
Manner
(A) Table showing the 10 proteins form pig brain
cytosol as scored by their iBAQ values that are
most enriched in their binding to GST-Pcore over
GST-core. The top two ‘‘hits’’ are NECAP1 and
NECAP2.
(B) Myc-tagged Pcore preferentially binds to full-
length recombinant NECAP in pull-downs. SDS-
PAGE gels were blotted and stained with Ponceau
red (upper) or developed with anti-myc antibody
(lower).
(C) Pcore binds more tightly to NECAP1 PHear
than the phosphorylated m2 linker. Representative
ITC traces (top) and fitted curves with KDs of
binding (bottom) of Pcore in red and to m2-linker
(residues 149–163)-derived peptide (cell) in blue
to WT NECAP1 PHear (syringe).
(D) SDS-PAGE gels of ‘‘pull-downs’’ using His6
NECAP1 constructs of various length immobilized
on NiNTA beads were blotted and stained with
Ponceau red (upper panels) and developed with
anti-myc antibody (lower panel), showing that
PHear and PHear-Ex but not Ex bind to Pcore.
(E) SDS-PAGE gels of ‘‘pull-downs’’ using His6
NECAP1 PHear immobilized on NiNTA beads
shows that NECAP PHear binds GSTm2 linkers
122–171 and 149–163 only when T156 is phos-
phorylated by co-expression of linkers with the
AAK1 catalytic subunit.
(F) NECAP1 PHear only binds m2 linker peptides
when the peptides are phosphorylated: KD of
55 mM. Example ITC traces (top) and fitted curves
with KDs of binding (bottom) of WT NECAP1
PHear (cell) to m2-linker- (residues 149–163)
derived peptides (syringe): Q154S + G157A (ki-
nase ablation)mutant, red;WT unphosphorylated,
cyan; and T156-phosphorylated, dark blue.
(G) Comparison of the quantity of endogenous
NECAP that co-immunoprecipitated with AP2
from lysates obtained from control cells (first lane)
and cells treated with LP and m2NAK RPE cells
(middle and last lane) by western blotting with anti
NECAP polyclonal antibody. AP2 binds NECAPs
only when AP2 is m2T156 phosphorylated.
(H) Representative immunofluorescence images
showing co-localization of EGFP-CLCa, NECAP1,
and AP2 (top row) and EGFP-CLCa, NECAP1, and
P-AP2 when treated with DMSO (middle row) or
LP (bottom row). White arrows indicate the pres-
ence of a fluorescent signal in the EGFP-CLCa
channel and the same position in the NECAP (red channel) and AP2 or P-AP2 channel (cyan channel). Scale bar, 5 mm.
(I) Comparison of PCCs to assess the relationship of the paired intensity values of CCP components EGFP-CLCa, NECAP, AP2, and P-AP2 from immunoflu-
orescence images. Data represent the mean SD, n = 30. Two-tailed Student’s t tests were used to assess statistical significance. **p% 0.01, ****p% 0.0001.interaction is direct and completely dependent on phosphoryla-
tion of m2T156 (Figure 4E).
The phosphorylated m2 linker is largely invisible, i.e., disor-
dered and accessible in the open+ as well as in the closed Pcore
structures and thus should be able to bind NECAP PHear do-
mains in both conformations. ITC using a phosphorylated m2
linker synthetic peptide of 15 residues (SQITSQV(pT)GQIGWRR)
and NECAP1 PHear domain demonstrated that the interaction
possessed a KD 55 mM (Figures 4F and S4E). No binding could
be detected for non-phosphorylated m2WT or m2NAK linker pep-500 Developmental Cell 50, 494–508, August 19, 2019tides (Figure 4F), control threonine phosphorylated peptide
IKIIDEK(pT)GVIEHE, or free phosphothreonine (Figure S4F), indi-
cating that the binding of the isolated linker to PHear was largely
mediated by the phosphothreonine but only occurred when it
was presented in the correct context. The strength of binding
of the isolated phosphorylated linker is somewhat weaker than
that of the phosphorylated linker when it is part of Pcore, in
agreement with the ‘‘pull-down’’ data (Figure S4D). This differ-
ence suggests the existence of another, albeit weak, determi-
nant for PHear binding, on closed Pcore at least. Whether this
Figure 5. A m2T156 Phosphorylation Drives NECAP Recruitment to CCPs
(A and B) CCPs detected in control RPE cells expressing EGFP-CLCa and NECAP1-mRuby2 were grouped into cohorts with a specific range of lifetimes, and
corresponding intensity traces of EGFP-CLCa and NECAP1-mRuby2 were plotted as a function of the time. CCPs were further subcategorized into NECAP-
positive CCPs (A) and NECAP-negative CCPs (B). Averaged CCP intensity traces for EGFP-CLCa (green) and NECAP1 (red) from control cells are shown as
mean ± SE (shaded areas) per lifetime cohort.
(C) Lifetime distributions of all CCPs (gray) in control RPE cells expressing EGFP-CLCa and NECAP1-mRuby2. CCPs were further subcategorized as NECAP1-
positive (red) or NECAP1-negative (blue) for comparison of lifetime distribution between the two populations of CCPs.
(legend continued on next page)
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additional site also exists on a cargo-binding competent form of
Pcore, we cannot say.
A high mMKD interaction between the AP2 a-appendage and a
WxxF motif at the C terminus of mammalian NECAP-1 has been
characterized (Praefcke et al., 2004; our unpublished data). To
explore the contribution of both sites of interaction, the WxxF
motif and PHear as part of full-length NECAP, we used a
p-AP2 core that contains a-appendage separated from the
a-trunk by a synthetic linker of the correct length, which circum-
vents its rapid proteolysis. The presence of both cognate binding
surfaces on both partners caused avidity effects and result in a
comparatively stronger interaction (Figure S4D) and hence a
NECAP:AP2 complex could be isolated by gel filtration (data
not shown). Although our attempts to crystallize such a complex
sadly proved unsuccessful, these data indicate that the a-ear
binding could provide a further determinant in addition to the
phosphorylated m2 linker to augment P-AP2’s ability to bind or
recruit NECAP in mammalian cells but not in C. elegans.
Efficient Recruitment of NECAPs to CCPs Is Dependent
on Phosphorylation of AP2
To explore the dependency of the interaction between NECAPs
and AP2 on its phosphorylation, we used native co-immunopre-
cipitation of endogenous proteins from RPE cell lysates under
low-detergent conditions. In RPE cells, both NECAP1 and
NECAP2 interact with P-AP2. We found that in all conditions
the NECAP1:AP2 and NECAP2:AP2 interaction was nearly
undetectable in the absence of m2T156 phosphorylation, result-
ing from LP inhibitor treatment or using the m2NAK mutant
(Figure 4G).
To investigate if therewas a correlation between the phosphor-
ylation of AP2 and presence of NECAP1-mRuby2 (Figure S4G) in
CCPs, we used quantitative analysis of immunofluorescence
images (Figure 4H). We observed a strong positive correlation
between the quantity of NECAP1-mRuby2 and EGFP-CLCa and
total AP2 and P-AP2 in CCPs. Treatment with LP inhibitor signifi-
cantly reduces the quantity correlation between each pair of CCP
components, with the largest drop being between NECAP1-
mRuby2 and P-AP2 (Figure 4I). The histograms in Figure S4H
show that the proportion of CCPs positive for NECAP1-mRuby2
increases with the amount of EGFP-CLCa. The same is true for
the NECAP1-mRuby2 and total AP2 and NECAP1-mRuby2 and
P-AP2. The probability of finding NECAP1-mRuby2 increases
most rapidly with the quantity of P-AP2. LP inhibitor treatment
reduced the probabilities in all three cases (Figure S4H).
NECAP Is Recruited to CCPs Early and Regulates CCP
Maturation
The recruitment profile of NECAP1-mRuby2 was analyzed
by dual-color live-cell TIRFM (Figures 5A and 5B; Video S1).
NECAP1-mRuby2 was present in 65% of CCPs. In these
CCPs, the recruitment profile of NECAP1-mRuby2 paralleled(D) Number of CCPs identified as NECAP1-positive or NECAP1-negative in contro
calyculin A (see Figure S5), and m2NAK RPE cells. Values are mean ± SD, n= 18
(E and F) CCPs detected in RPE cells expressing EGFP-CLCa andNECAP1-mRub
of lifetimes, and corresponding intensity traces of EGFP-CLCa and NECAP1-mR
(G and H) Scatterplots with values of density of persistent structures (G) and aver
and NECAP1 + NECAP2 depleting siRNAs (green). Lines represent mean and SD
502 Developmental Cell 50, 494–508, August 19, 2019that of the EGFP-CLCa as the CCP grows (Figure 5A). Most
NECAP-positive CCPs have lifetimes over 30s (Figure 5C),
whereas NECAP-negative CCPs are predominantly short lived.
This distinct separation of lifetime distributions between
NECAP-negative and NECAP-positive CCPs is similar to that
previously described for dynamin positive versus negative
CCPs (Aguet et al., 2013). Strikingly, the clathrin recruitment pro-
file changed shape in NECAP-negative CCPs, especially in life-
time cohorts <40–60 s, acquiring a significant plateau followed
by an extremely rapid (<5 s) complete loss in the EGFP-CLCa
signal (Figure 5B). The short lifetimes of NECAP1 negative
CCPs together with their distinct EGFP-CLCa intensity profiles
may be indicative of a rapid disassembly process characteristic
for labile clathrin coat rather than regulated membrane deforma-
tion into U structure and scission of the CCP.
LP inhibitor treatment reduced the number of CCPs that recruit
NECAP1-mRuby2 to 31% of all CCPs and the overall levels of
NECAP1-mRuby2 declined by 50% (Figures 5D–5F). The cla-
thrin-coated persistent structures in LP-treated cells (defined
and analyzed in Figures 1G and 1H) are frequently deficient in
NECAP recruitment (Figure S5A). The inhibition of protein phos-
phatase activity with Calyculin A increases the number of
NECAP1-mRuby2-positive CCPs to 80% (Figure S5B). These
experiments were repeated with NECAP2-mRuby2 and yielded
very similar results (data not shown). The siRNA-mediated simul-
taneous depletion of both NECAP1 and 2 (Figure S5C) led to
slower rates of CCP formation, an increase in the number of
persistent structures (Figures 5G and 5H), and reduced rates of
TfRuptake (FigureS5D). Interestingly, upondepletion of just a sin-
gleNECAP isoform,weobservedconcomitant upregulation of the
other NECAP isoform (Figure S5C). The compensatory upregula-
tion of a singleNECAP isoformmayexplain themild effects onTfR
internalization that we observed (Figure S5D, first two panels).
In conclusion, the quantity of NECAP1 in CCPs is positively
correlated with the level of P-AP2. NECAPs are recruited in
increasing amounts over time to themajority of CCPs throughout
their life in a manner dependent on m2T156 phosphorylation.
Quantification of the immunofluorescence images (Figures S5E
and S5F) and the resulting scatterplot show that there is also a
positive association between the quantity of cargo (TfR) and
NECAP in P-AP2 positive spots. This merely reflects that as
the CCP grows it can accommodate more cargo since neither
m2T156-phosphorylation (Figure S3H) nor the additional pres-
ence of excess PHear domain (Figure S5G) affect AP2’s affinity
for cargo. These data indicate that NECAP functions as a posi-
tive regulator of CCP growth and maturation by a mechanism
that we subsequently investigate.
Structure of the NECAP1 PHear Domain in Complex with
T156-Phosphorylated m2 Linker
We probed the molecular details of the interaction by de novo
determining the structures of the PHear domain and al cells, cells treated with LP inhibitor (see [E] and [F]), pan-phosphatase inhibitor
.
y2 and treated with LP inhibitor were grouped into cohorts with a specific range
uby2 were plotted as a function of the time as in panels (A) and (B).
age lifetime of the 95th percentile (H) for cells treated with control siRNA (blue)
for each group, n = 20.
Figure 6. Mechanism of NECAP1 PHear Domain Binding to T156 Phosphorylated m2 Linker
(A) Family of the 30 lowest energy structures of the PHear domain of NECAP1 (colored blue N to red C) in complex with the T156 phosphorylated linker peptide
(residues 149–163 colored pale to dark purple) of Cm2.
(legend continued on next page)
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complex between the PHear domain and the m2 linker peptide
SQITSQV(pT)GQIGWRR using multidimensional, heteronuclear
NMR (Figures 6A and S6A–S6D; Table S4). The NECAP1 PHear
domain is a member of the PH fold superfamily, having a seven
stranded antiparallel b-sandwich core, one edge of which is
packed against by the long C-terminal a-helix (Figure 6A) (Ritter
et al., 2007). Comparison of the liganded and unliganded struc-
tures shows that peptide binding does not alter PHear domain
conformation (Figures S6A–S6D). The phosphorylated m2 pep-
tide binds in a shallow groove lined with basic and hydrophobic
residues. The main contacts are mediated by the side chains
of R90 and R113, which are located within 3–4 A˚ of the phos-
phate group of the peptide throughout the ensemble of struc-
tures (Figures 6B–6D) and the side chain of S89, which contacts
the backbone of R162 of the m2 linker. The other significant
peptide:domain interaction is made between V155 of the m2
linker sitting in a shallow pocket formed by A33, L38, and T86,
explaining why the mutant V155A phosphorylated m2 peptide
shows almost no binding to PHear (Figure S6E). The side chains
responsible for the binding show very high conservation across
150 homologous sequences of 35%–95% identity (chosen
across animals, plants, and fungi kingdoms), as determined
with ConSurf (Ashkenazy et al., 2010) using HMMER search
over UNIREF90 database with E value 0.0001 (Figure 6J). The
rest of the peptide is disordered.
Structure-based mutations, which did not affect the domain’s
fold as determined by circular dichroism and physical properties
(data not shown), confirmed the mode of binding: mutation of
R90A, R113D, and S89D and a double mutation of A33S/L38S
abolished binding of the phosphorylated m2 peptide, while muta-
tion of S88A and R32D reduced binding (Figure 6K; Table S5). In
contrast, mutation of R102A, which abolishes FxDxF binding (Rit-
ter et al., 2007) andmaps to a different patchon thePHear domain
surface, had no significant effect on m2 phosphopeptide binding
(Figure S6E). There are two further indications that the binding
sites for P-AP2 and Bin1/amphiphysin/RVS167 (BAR) domain
proteins are independent, and hence can bind their ligands simul-
taneously: firstly the two sites are located on opposite faces of the
PHear domain, and secondly a20-fold molar excess of the am-
phiphysin-derived CSFFEDNFPE peptide has no obvious effect
on the binding of the phosphorylated m2 peptide to PHear in ITC
or of Pcore to PHear in pull-downs (Figures S6E and S6F). N.b.,
the binding of FxDxF peptide to PHear in ITC gave data of insuffi-
cient quality to be reliably processed. To confirm this,mass spec-
trometry analyses ofGSTpull-downs frombrain cytosol were car-
ried out usingwild-type (WT), R90A, R102A, and an R90A+R102A
double mutant (Table S6). Amphiphysin1,2 and Bin2,1 were the(B and C) Enlargement of best 10 structures (B) and single best structure (C) of
mutants Arg90Ala and Arg113Ala with carbons in light and dark green, respectiv
(D, E, G, and H) PHear:phospho m2 peptide complex showing residues whose mut
interaction as determined by ITC in (J). Mutations that do not affect NECAP bindin
red and m2 peptide in purples.
(F and I) Electrostatic potential of PHear to highlight basic binding pockets of bot
placed on after potential calculation.
(J) PHear:phospho m2 peptide complex colored according to the ConSurf cons
sequence identity using the ConSurf algorithm.
(H) Example ITC traces (top) and fitted curves with KDs (bottom) of binding of WT (d
(syringe).
504 Developmental Cell 50, 494–508, August 19, 2019most abundant proteins in a pull-downwithNECAP1 1–133. Their
capture was not affected by the R90A mutation, but capture
massively decreased (>29-fold) in the pull-down with R102A and
the double mutant R90A/R102A. We note that AP2 capture was
affected significantly, not only by the R90A mutation but also by
the R102A mutation. This may be due to AP2 being at the hub of
a large interaction network involving proteins binding via FxDxF
motifs at the R102 site: in line with this, the levels of AP2 detected
on pull-down with the double R90A/R102A mutant, decreased to
the limits of detection.
Point Mutation of R90 Inhibits Recruitment of NECAP
to CCPs
NECAP1-mRuby2 WT or R90A were expressed at near endoge-
nous levels in a background of siRNA-mediated depletion of
endogenous NECAPs (Figures S6G and S6H). Native co-immu-
noprecipitation of AP2 demonstrated that the R90A NECAP1
showed60% reduction in binding to P-AP2, and its expression
caused 20% reduction in the TfR internalization rate as
compared with re-expression of NECAP1-mRuby2 WT (Figures
S6I–S6K). Further, we observed by TIRFM that NECAP1-R90A
caused 50% reduction in recruitment to CCPs, which pheno-
copies reduced NECAP recruitment upon NAK inhibition.
NECAP Links P-AP2 and the PX-BAR Proteins to
Coordinate CCP Maturation
To quantitatively assess the changes in the AP2 interactome
upon its phosphorylation, we used Stable Isotope Labeling
with Amino acids in Cells (SILAC)-based proteomics combined
with native co-immunoprecipitation of AP2. Since the NECAP
PHear domain binds P-AP2 and can simultaneously bind endo-
cytic accessory proteins via FXDXF motifs, this interaction sur-
vey should also identify binding partner(s) of NECAP. RPE cells
were treated with LP inhibitor, while control cells were treated
with just DMSO. NECAP1 and NECAP2, as expected but also
the PX-BAR protein SNX9, underwent significant and reproduc-
ible depletion upon the inhibition of m2T156 phosphorylation
(Figure 7A). ITC measurements revealed that SNX9 can interact
directly with NECAP via an FLDSL sequence in the unstructured
linker that joins its SH3 and PXBAR domain, albeit with only
moderately low affinity (Figure S7A), and this interaction is also
seen upon immunoprecipitation of NECAP1-mRuby2 from cells
(Figure S7B). SNX9 is a late stage CCP component that coordi-
nates steps leading to membrane remodeling, PIP interconver-
sion, and vesicle scission (Lo et al., 2017) and is abundantly ex-
pressed in non-neuronal cells. A portion of the SNX9 linker
adjacent to the accessible FLDSL sequence, containing thethe linker binding site, showing side chains of the strongest binding-abolition
ely. Phosphate group is shown in purple (phosphorous) and red (oxygens).
ation strongly (light green, dark green, and orange) or mildly (yellow) affects the
g but do affect amphiphysin and CALM binding via FxDxF motifs are shown in
h binding sites colored from +10eV (blue) to 10eV (red). m2 peptide in purples
ervation score (bottom) based on alignment of 150 sequences of 35%–95%
ark blue) andmutants of NECAP1 PHear (cell) to WT m2 linker phosphopeptide
Figure 7. NECAP Recruits BARDomain Pro-
teins, Leading to CCV Scission
(A) Analysis of the P-AP2 interactome. Volcano plot
obtained from SILAC-based quantitative prote-
omics analysis of proteins that co-immunoprecip-
itated with AP2 in lysates obtained from control
RPE cells treated with DMSO or cells treated with
LP. Red dots represent proteins exhibiting signifi-
cant (p < 0.05) fold enrichment in the P-AP2 inter-
actome. n = 6.
(B) Averaged CCP intensity traces for EGFP-CLCa
(green) and SNX9 (red) from control cells (top left)
and cells treated with NECAP1/2 siRNA (top right),
and LP (bottom) are shown as mean ± SE (shaded
areas) per lifetime cohort.
(C) Schematic model of CCP maturation leading to
CCV scission. The evolving CCP structure and the
phases it passes through are shown at the top. The
middle represents the degree of m2T156 phos-
phorylation and cartoons of the individual com-
ponents and their recruitment is shown below.sequence DPWSAW has been implicated in autoinhibition of
SNX9 functions through binding back to and inactivating the
membrane binding of the SNX9 BAR domain (Lo et al., 2017).
The SNX9:NECAP PHear interaction should facilitate or trigger
SNX9 activation by sterically inhibiting the DPWSAW binding
back, freeing it, and allowing it to bind to the AP2 a-appendage
and/or clathrin W-box site (Lo et al., 2017; Miele et al., 2004) and
maintain SNX9 in an active conformation.
We tested the hypothesis that SNX9 recruitment and activa-
tion in CCPs may be dependent on the presence of NECAPs
and their association with P-AP2 using TIRFM (Figure 7B).
SNX9 recruitment to CCPs was blocked in cells depleted for
NECAP1, 2 (Figure 7B; Video S2), and upon LP treatment,
SNX9 recruitment was reduced by 50% as shown in lifetime co-
horts in Figure 7B. Further, in control cells SNX9 is recruited later
than NECAP, and in the majority of CCPs, SNX9’s maximum
recruitment rate occurs around the time of, or after, the peak
of maximal NECAP recruitment (Figure S7C).
To confirm these data in other cell lines, we used NECAP1
1–133 as bait in ‘‘pull-down’’ experiments with cytosolic extracts
of three non-neuronal cell lines (HeLa, RPE, and HepG2). Identi-
fication of the bound proteins by mass spectrometry (Table S7)
revealed that CALM (a previously noted partner of NECAP PHear
[Ritter et al., 2013]) and SNX9were the twomost abundant endo-
cytic proteins bound. Taken together with their domain compo-
sitions, these data suggest that SNX9 in non-neuronal cells and
Amphiphysin1,2/Bin2,1 in neuronal cells are equivalent NE-DevelopmeCAP1,2 binding partners whose recruit-
ment to CCPs is driven by AP2
phosphorylation.
DISCUSSION
The formation of a new CCP can be
initiated either de novo by a pioneer com-
plex of AP2 assisted by Fcho1/2 and
Eps15/R (Hollopeter et al., 2014; Ma
et al., 2016) or on the edge of existinglarge flat clathrin-coated structures (Lampe et al., 2016). In the
productive situation, the clathrin:adaptor coat grows and
together are deformed to form an ‘‘U’’ structure (Heuser, 1980;
Kukulski et al., 2012). The CCV proceeds to scission from the
parent membrane and finally to coat removal, triggered by
PtdIns4,5P2 hydrolysis and HSC70/Auxilin-mediated clathrin-
cage disassembly (He et al., 2017). All CCPs should ideally incor-
porate cargo and proceed toward completion of CCV scission,
however, it is necessary that an off-path route exists so that
CCV formation can be aborted under unfavorable circumstances
(e.g., a lack of cargo) (Mettlen et al., 2018). This would ensure
that the process does not become stalled with CCV components
trapped in partly formed, non-productive structures.
Here, we have presented data showing that m2T156 p-AP2
appears early and increases throughout CCP formation and
that m2T156 phosphorylation should favor conformational
change to an open+ active conformation. Since both open
and open+ forms of AP2 permit clathrin binding by release
of the b2 linker (Kelly et al., 2014), both can participate in
stabilizing CCP nucleating structures by recruiting clathrin.
Various assays show that m2T156 phosphorylation does not
have a major effect on cargo and membrane binding by AP2,
which is supported by structures showing that cargoes bind
to Pcore and core in mechanistically identical manners.
m2Thr156 phosphorylation favors AP2, adopting a previously
uncharacterized, cargo-bound conformation (Figure S7E), and
thus in the absence of AP2 phosphorylation in cells, thental Cell 50, 494–508, August 19, 2019 505
equilibrium between AP2 conformations may be shifted toward
the closed form: this could potentially result in a subtle deficit in
cargo accumulation in CCPs on NAK kinase inhibitor treatment.
We show that m2T156 phosphorylation by NAK kinases in-
creases AP2’s affinity for NECAPs. This drives NECAP recruit-
ment into endocytic CCPs, which we show also starts early in
and increases throughout a CCP’s life. In themammalian system,
NECAP recruitment to AP2 is robust due to avidity effects caused
by simultaneous recognition of theWxxFmotifs at the C terminus
of NECAP by the AP2 a-appendage along with the binding of the
NECAPPHear to thephosphorylated them2 linker. The latter inter-
action will also mask T156 from dephosphorylation (Figure S7D).
Further strength of binding could be derived froma possible inter-
action of the NECAP ‘‘ex’’ fragment with the b2 subunit (Ritter
et al., 2013). Avidity-effect-enhanced binding of NECAP to
a-appendage will also compete off NAK kinase bound to P-AP2,
principally by its own WxxF motif so that it can phosphorylate
further AP2s. There is 20-fold less AAK1 than AP2 in mammalian
cells (Itzhak et al., 2016). N.b., there is also 4 times less AAK1 than
NECAP (Itzhak et al., 2016). The competitive binding between
AAK1 and NECAP to AP2 is also captured by quantitative prote-
omics using SILAC (Figure 7A). This complexity, based on the
co-operativity between multiple binding modes of NECAP to
AP2, together with the competition for binding with other CME
players increases the specificity and adds further regulatory con-
straints on CCP growth, especially in higher vertebrates.
NECAP PHear can bind late-stage components of the CCV
machinery such as SNX9, amphiphysin1,2/BIN2,1, and CALM
(this work and Ritter et al., 2007; Ritter et al., 2013), while simulta-
neously being bound to P-AP2. This is possible because their
respective binding sites are on distinct, non-overlapping sites
on the NECAP PHear. The PHear-binding site on P-AP2 will be
adjacent to themembrane surface due to the position of its phos-
phorylated m2 linker, and thus a multi-attachment point recruit-
ment platform for these late-stage membrane-remodeling com-
ponents will be created at their site of function. As a side note,
the FXDXF binding platform of the NECAP PHear domain is not
conserved in C. elegans and concomitantly the FXDXF motif is
absent in the C. elegans orthologs of the BAR domain proteins.
The fastest recruitment rates of SNX9 and amphiphysin1,2/
BIN2,1 occur at the late stage of CCPs formation (Taylor et al.,
2011 and this work). The final stage of CCV genesis is the recruit-
ment by these BAR domain proteins of dynamin (whence it can
form a ‘‘collar’’ to drive CCV scission) and synaptojanin (respon-
sible for PtdIns(4,5)P2 and PtdIns4P hydrolysis (Aguet et al.,
2013; Antonny et al., 2016; He et al., 2017; Owen et al., 1998).
Thus, recruitment of NECAPs ultimately drives the completion
of CCV formation, and hence, NECAP is a positive factor in endo-
cytic CCP formation in mammalian cells. Indeed, in line with our
model, we see that disruption of this phosphorylation-induced
NECAP-based recruitment or depletion of NECAP itself, leads
to a slowing down of the rate of the late stages of CCP matura-
tion and an increase in the number of persistent, diffraction-
limited, presumably stalled endocytic structures. This is
consistent with the observed decrease in CME efficiency. It is
interesting to note that depletion of SNX9 or dynamin, which
either bind NECAP directly (SNX9 via FXDXF motif) or indirectly
(dynamin via SNX9/amphiphysin1,2/BIN2,1) phenocopies both
these effects of NECAP depletion (Antonny et al., 2016; Lo506 Developmental Cell 50, 494–508, August 19, 2019et al., 2017). Such a model in which as the CCP protein coat
grows through binding of clathrin adaptors via PtdIns4,5P2,
more cargo is incorporated by AP2, which in turn becomes pro-
gressively more phosphorylated by NAK to efficiently recruit
NECAP and SNX9 and finally dynamin, is depicted in Figure 7C.
Thus, ‘‘feed-forward’’ control of the CCV formation pathway is
defined through cargo-bound AP2 recruiting clathrin, which may
in turn stimulate NAK-kinase-catalyzed phosphorylation of
AP2 m2T156. This then recruits NECAPs and subsequently
their late-phase, membrane-remodeling, binding partners to the
CCP. Hence, final membrane deformation and CCP scission will
not occur efficiently until sufficient NECAP molecules and their
bound late stage factors have been recruited. m2T156 phosphor-
ylation and NECAP recruitment can thus be considered to be at
the center of the major decision that has to be ‘‘taken’’ of whether
to proceed to completion of CCV formation with all the energy
expenditure that would entail or to abort. Thus, AP2 phosphoryla-
tion followed by NECAP recruitment should be seen as a way of
maximizing the chance of a CCV being ‘‘worth’’ forming, explain-
ing why NAK kinase inhibition or depletion of NECAPs result in a
reduction inCME efficiency rather than causing a complete block.
Additionally, our ITC data (Beacham et al., 2018) also suggest
that by being able to bind closed P-AP2 in solution (Jackson
et al., 2010), NECAPs could play a further, accessory role in
CME by binding and stabilizing closed P-AP2 that has dissoci-
ated from a CCP membrane and so inhibit the P-AP2 from re-
binding the membrane. To be consistent with our in vivo data,
we surmise that NECAP would not be capable of significantly
moving the equilibrium of open+ PAP2 to a closed conformation
due to the open+ conformer being greatly stabilized by its simul-
taneous binding to multiple PtdIns4,5P2s and cargo. This func-
tion of NECAP could be especially useful at the CCP neck, where
BAR proteins will have become concentrated and the presence
of PtdIns4,5P2-binding dynamin spiral oligomers (Antonny et al.,
2016) together will compete with AP2 for membrane PtdIns4,5P2
binding. Stabilizing unattached P-AP2 that has been locally
competed off the neck region would facilitate neck scission by
removing steric clashes between dynamin spirals and cargo-
bound P-AP2. Such an additional role for NECAP is completely
consistent with the data presented here.
In summary, the clathrin-activated NAK-kinase-catalyzed
phosphorylation of the AP2 m2linker stabilizes a cargo-binding
competent conformation of AP2 in early and growth stages of
CCV genesis. Throughout the lifetime of the CCP, P-AP2 is also
pivotal to recruiting NECAP. NECAPs ability to simultaneously
bind to P-AP2 and late stage components of CCV biogenesis
means it can mediate the temporally appropriate recruitment of
these latter proteins, which are necessary to convert mid-stage
CCPs into mature CCVs. The interplay between the activating
conformational changes in AP2, its phosphorylation, and the re-
sulting recruitment of NECAPs confers direction and control on
the process of endocytic CCV formation.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Culture
Human retinal pigment epithelial cells (hTERT-RPE-1) were used as a parental cell line. It was obtained from ATCC and cultured in
DMEM medium (31966-021, Thermo Fisher Scientific-Gibco) supplemented with 10% FBS (Thermo Fisher Scientific). All cells were
cultured at 37C under 5% CO2. Cell lines were routinely tested for absence of mycoplasma contamination with MycoAlert Myco-
plasma Detection Kit (Lonza). HepG2 and HeLa S3 cells used for preparation of cytosolic extracts were also obtained from the ATCC
and were cultured under the same conditions.
METHOD DETAILS
Bacterial Expression Constructs
The constructs for bacterial expression of AP2 pMWHis6b2t+m2myc, pMWHis6b2t+m2myc+AAK1(1-325), pMWatGST+s2,
pMWaGST+s2 were as described in (Ho¨ning et al., 2005).
The constructs for expressing AAK1 constructs, pET28bAAK1 (1-317) and (26-350) were made by cloning the appropriate length
fragments of AAK1 into the NcoI and XhoI of pET28b.
The following constructs were created for bacterial expression of various forms of NECAP1. pET28bHis6-NECAP1 (1-275),
pET28bHis6-NECAP1 (1-133) were both created by cloning appropriate length fragments of NECAP1 into pET28b using NdeI and
NotI sites. pGEX4T3NECAP1(1-275), pGEX4T3NECAP1(1-133) and pGEX4T2NECAP133-275 were created by cloning appropriate
fragments of NECAP1 into pGEX4T3 using EcoRI and NotI sites. Point mutant versions A33S, S88A, S89D, R90A, R90D, R95A,
R102A, R113A NECAP1(1-133) were generated using standard pcr-based mutagenesis in pGEX4T3NECAP1(1-133).
To make a construct for expressing GST alone, termed pETHis6-GST, GST was cloned using XbaI and EcoRI sites into pETM30.
All constructs were verified by sequencing.
Protein Purification
Phosphorylated and non-phosphorylated AP2 heterotetramers were expressed and purified as previously described (Collins et al.,
2002; Ho¨ning et al., 2005). Phosphorylation was achieved by co-expression with the kinase catalytic domain (residues 28-333 of theDevelopmental Cell 50, 494–508.e1–e11, August 19, 2019 e3
Homo sapiens AAK1) and estimated by mass spectrometry as >95% and occurring at the single site m2 Thr156 (Collins et al., 2002;
Ho¨ning et al., 2005).
NECAP1 GST-fusion proteins were expressed in E. coli BL21DE3 pLysS at 22C for 16 hours. Cells were lysed and insoluble ma-
terial removed by centrifugation. Proteins were bound to GST sepharose in bufferA (200 mM NaCl, 20 mM TRIS pH 7.4) and washed
extensively with 100 volumes of bufferA and the proteins cleaved from GST by overnight incubation at 22C with thrombin. Cleav-
age was halted by the addition of 0.1 mMAEBSF and the free proteins collected and concentrated to c. 20mg/ml and further purified
by S200 gel filtration in appropriate buffers. Full length NECAP1 was appended at its C-terminus with a His6 tag and this protein was
additionally purified using NiNTA agarose to remove non-full-length material.
Protein Crystallization and Structure Determination
Crystals of Pcore in its locked/closed state were grown by hanging drop vapour diffusion of a solution containing 12.5 mg/ml protein
and 0.5 mg/ml inositol hexakisphosphate against a reservoir containing 20% PEG 1000; 100 mM Na+/K+ phosphate buffer (pH 7.2),
200 mM NaCl, and 10 mM DTT. The crystals were mounted and cryo-protected in a solution containing: 25% glycerol, 20% PEG
1000; 100 mM Na+/K+ phosphate buffer (pH 7.2), 200 mM NaCl, and 10 mM DTT, prior to flash cooling by plunging them into liquid
nitrogen. The crystals were of the space group P 31 2 1with onemolecule in the asymmetric unit cell of dimensions 121A˚, 121A˚, 258A˚;
90, 90, 120 and diffracted at best to 2.6 A˚ at the Diamond Light Source beam line IO4-1. The data were integrated with Mosflm and
scaled and merged in Aimless. The structure was solved using Phaser with the closed core structure (PDB ID 2VGL) as a search
model and refined using alternating cycles of Refmac and manual rebuilding in Coot to the final R and Rfree of 0.230 and 0.259
respectively (Table S1). When overlaid, the Pcore and core structures exhibited RMSD of 0.56 over 1717 residues with loops missing
in 2VGL also being missing in the Pcore equivalent.
Crystals of AP2 Pcore and core in the open+ state were grown by hanging drop vapour diffusion from a solution containing
12 mg/ml AP2 core or Pcore, 1mg/ml TGN38 YxxF-based cargo peptide DYQRLN, and 5 mg/ml functional variant dileucine cargo
RM(P)SEIKRLLSE from CD4 against a reservoir containing 7.5% PVA, 9% 1-propanol, 90 mMHepes pH 7.4, and 100 mM guanidine
hydrochloride over a period of two days. Drops were set up with a 2:1 protein/precipitant ratio. The crystals were cryo-protected with
8% PVA, 12% 1-propanol, 90 mM Hepes pH 7.4, 100 mM guanidine hydrochloride, 20% glycerol, 1 mg/mL TGN38 peptide, and
5 mg/mL CD4 peptide before being plunged into liquid nitrogen. Data were collected at the Diamond Light Source beam lines IO4
and IO4-1, integrated in Mosflm and were of the space group P41 21 2 with unit cell dimensions of 182 A˚, 182 A˚, 211 A˚; 90, 90, 90.
For the Pcore, data from five crystals diffracted to better than 4A˚ resolution but all were prone to radiation damage. Initially, each
dataset was independently scaled and merged in Aimless and the structure was solved for several combinations of datasets with
Phaser, using the open form (PDB ID 2XA7) as the search model. In the end, an ‘‘optimal’’ data selection was chosen by comparing
the data from the five crystals with the calculated intensities from the initial model, as a function of image number: data from two
crystals and from the later parts of two others were rejected as having too much radiation damage, leaving data from three crystals.
Using this data set, the best molecular replacement solution was found using the bowl (a trunk, b2 trunk, Nm2, s2) from the open form
and the Cm2 domain from the same structure as independent searchmodels (as opposed to the bowls andCm2 structure of other AP2
complexes). This final solution still exhibited very weak electron density for the first 80 to 100 amino acids of the N-terminal part of the
b2 trunk although fully present as shown by complete rebinding of an aliquot of the crystallised Pcore to NiNTA resin through the His6
tag on the very N-terminus of b2 (data not shown). Various approaches were employed in an effort to locate these missing residues
but all failed. Extensive refinement was carried out on the structure using Refmac. The initial refinement was attempted using rigid
bodies with a hope that it would reveal the density for the N-terminal part of the b2 solenoid. As it did not, the b2 solenoid up to the
residue 87was removed, as the electron density around this region remained very weak. Prosmart was used to generate restraints for
low-resolution refinement. Finally rounds of TLS refinement (using TLS groups previously determined for the open structure; Jackson
et al., 2010), standard restrained refinement, and restrained refinement with the ‘‘bowl’’ restraints from the open structure and from
Prosmart were all alternated with manual structure adjustment in between refinements in coot. Using this approach, the 3.4 A˚ struc-
ture of the AP2 Pcore in a new, open+ conformation was determined and refined to R=0.205 and Rfree=0.247 – the best statistics for
an AP2 structure to date. DEN refinement and feature-enhancedmaps were used with the hope of revealing more features in the final
maps but both failed.
Crystals of the AP2 core in the open+ state diffracted significantly worse than those of the Pcore. The best dataset was collected
from a single crystal diffracting to 6 A˚ at the Diamond Light Source beam line IO2. The data were integrated with Mosflm and scaled
and merged in Aimless and the structure was solved with Phaser using the Pcore open+ structure as a search model. The validity of
the obtained structure was confirmed by solving it again in Phaser using just the bowl (a trunk, b2 trunk, Nm2, s2) from the Pcore
open+ form. The resulting solution showed clear electron density corresponding to the Cm2 domain at the new position observed
only in the open+ conformation. The validated full open+ core structure was then refined in Refmac to R=0.259 and Rfree=0.285.
Crystallographic statistics of all three structures (Pcore closed, Pcore open+, and core open+) are listed in Table S1.
All programs used in crystallographic structure determinations were launched from and are part of CCP4 suite (Winn et al., 2011).
NMR Spectroscopy
NMR Sample Preparation
Samples for NMR were expressed in M9 minimal media supplemented with natural isotopic abundance glucose, vitamins, trace
elements, antibiotics, and 15NH4Cl (for single-labelled samples) or
13C6 glucose vitamins, trace elements, antibiotics, and
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(for double-labelled samples). Following purification by gel filtration, samples were exchanged into 75mM sodium acetate pH 6.5 us-
ing a PD10 column (GE Healthcare) in accordance with the manufacturers instructions for the ‘gravity’ method.
NMR samples of NECAP 1-133 comprised 0.3-0.6mM15N- or 15N,13C-labelled protein solutions in 70mM 2H3 acetate buffer pH 7.0
in 95:5 H2O:
2H2O or 99%
2H2O. In addition to the native NECAP residues 1-133, the sequence studied here carried a non-native
N-terminal sequence GSPNS (here numbered -4-0). NMR samples of the complex comprised 0.3-0.4mM equimolar mixtures of
15N- or 15N,13C-labelled NECAP 1-133 and natural abundance m2 149-163 in 70 mM 2H3 acetate buffer pH 7.0 in 95:5 H2O:
2H2O
or 99% 2H2O. NMR data were acquired using Bruker DRX600, AV-1 600, AV-3 800 spectrometers, each equipped with a cryogen-
ically cooled triple resonance (1H/15N/13C) 5mm probe. Experiments were conducted at 25C unless otherwise stated, and 1H chem-
ical shifts were calibrated using sodium 3,3,3-trimethylsilylpropionate (TSP) as an external 1H reference; 15N and 13C chemical shifts
were indirectly referenced to the 1H shifts using the ratio of gyromagnetic ratios. An essentially complete set of resonance assign-
ments was made using the experiments described below.
For H2O samples of free protein (
15N,13C-labelled NECAP 1-133), the following datasets were acquired: 2D datasets: [15N-1H]
HSQC; [13C-1H] HSQC (separate experiments acquired for aliphatic and aromatic regions in 13C); constant-time [13C-1H] HSQC
(separate experiments acquired for aliphatic and aromatic regions in 13C). 3D datasets: CBCANH; CBCA(CO)NH; HNCA;
HBHA(CO)NH; [1H-13C-1H] HCCH-COSY; [13C-13C-1H] HCCH-TOCSY; 15N NOESY-HSQC (tm = 150 ms);
13C NOESY-HSQC
(tm = 150 ms; separate experiments acquired for aliphatic and aromatic regions in
13C).
For H2O samples of complex containing 1:1
15N,13C-labelled NECAP 1-133 and natural abundance m2 149-163, the following data-
sets were acquired: 2D datasets: [15N-1H] HSQC; [13C-1H] HSQC (separate experiments acquired for aliphatic and aromatic regions
in 13C); [1H-1H] filtered NOESY (tm = 150ms) with filter elements set to reject protons coupled to
13C or 15N in F1 and to accept protons
coupled to 13C or 15N in F2, so as to detect intermolecular cross-peaks; [
1H-1H] filtered NOESY (tm = 50 ms, 150ms and 200 ms) and
[1H-1H] filtered TOCSY (tm = 40ms and 80ms), all with filter elements set to reject protons coupled to
13C or 15N both in F1 and in F2, so
as to detect intramolecular cross-peaks within m2149-163. 3D datasets: HBHA(CO)NH; HNCACB; 15N NOESY-HSQC (tm = 150 ms);
13C NOESY-HSQC (tm = 150 ms; separate experiments acquired for aliphatic and aromatic regions in
13C).
For 2H2O samples of complex containing 1:1
15N,13C-labelled NECAP 1-133 and natural abundance m2146-163, the following
datasets were acquired: 2D datasets: [13C-1H] HSQC (separate experiments acquired for aliphatic and aromatic regions in 13C),
constant-time [13C-1H] HSQC (separate experiments acquired for aliphatic and aromatic regions in 13C), [1H-1H] filtered NOESY
(tm = 150ms) with filter elements set to reject protons coupled to
13C or 15N in F1 and to accept protons coupled to
13C or 15N in
F2, so as to detect intermolecular cross-peaks. 3D datasets: [
1H-13C-1H] HCCH-COSY; [13C-13C-1H] HCCH-TOCSY; 13C NOESY-
HSQC (tm = 150 ms; separate experiments acquired for aliphatic and aromatic regions in
13C); 13C filtered NOESY-HSQC
(tm = 150 ms; separate experiments acquired for aliphatic and aromatic regions in
13C), with filter elements set to reject protons
coupled to 13C or 15N in F1, so as to detect intermolecular cross-peaks.
All of the NOESY datasets used for structure calculations (see below) were acquired using pulse sequences modified to ensure
equal RF heating in each case, e.g. for 13C experiments, a period of 15N decoupling equal in length to the acquisition period was
applied at the beginning of the interscan delay, and for 15N experiments an equivalent period of 13C decoupling was similarly applied.
Shift Perturbation Analysis
Backbone amide chemical shift perturbation analyses were performed by recording [15N-1H] HSQC spectra at 25C during addition
of natural abundance m2146-163 to 15N-labelled NECAP 1-133. Chemical shift perturbations were calculated according to Dd =
O((Dd(1H))2 + (Dd (15N) / 5.0)2).
Structure Calculations
Initial structures of free NECAP 1-133 and of NECAP 1-133:m2146-163 complex were calculated using the program UNIO 2.8.1
(Guerry et al., 2015), for which the input comprises the respective protein sequences, the full resonance assignment and the following
processed 3D NOESY spectrum files: 15N NOESY-HSQC (tm = 150 ms) in H2O,
13C aliphatic region NOESY-HSQC (tm = 150 ms) and
13C aromatic region NOESY-HSQC (tm = 150 ms) in H2O. For the complex,
13C aliphatic region NOESY-HSQC (tm = 150 ms) and
13C
aromatic region NOESY-HSQC (tm = 150ms) spectra acquired in
2H2Owere also used as input, and upper-limit distance restraint files
for intermolecular NOEs and intra-peptide NOEs were created following careful manual analysis of all the NOESY spectra and were
supplied as additional input data to the UNIO calculations. The standard UNIO protocol was employed that consisted of seven cycles
of NOESY peak identification, NOE assignment and structure calculation (Guerry et al., 2015). Each cycle comprised automated
NOESY peak picking with ATNOS (Herrmann et al., 2002b), use of the resulting lists of peak positions and intensities as input for auto-
mated CANDID NOE assignment (Herrmann et al., 2002a), and use of the final set of meaningful, non-redundant NOE distance re-
straints from CANDID as input for structure calculation using the simulated annealing routine of CYANA (G€untert et al., 1997). In each
UNIO–ATNOS/CANDID cycle, the output consisted of an updated list of assigned NOE cross peaks for each input spectrum and a
final set of meaningful upper limit distance restraints which constituted the input for the torsion angle dynamics algorithm of CYANA
for three-dimensional (3D) structure calculation. In addition, torsion angle restraints for the backbone dihedral angles f and c derived
from all backbone chemical shifts were automatically generated by UNIO and added to the input for each cycle of structure calcu-
lation. During the first six UNIO–ATNOS/CANDID cycles, ambiguous distance restraints were used. For the final structure calculation
in cycle 7, only distance restraints were retained by UNIO that could be unambiguously assigned based on the protein three-dimen-
sional structure from cycle 6.
Fifty structures were next calculated using XPLOR-NIH (Schwieters et al., 2003). As input, these calculations used the set of NOE
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employed r-6 summation for all groups of equivalent protons and non-stereospecifically assigned prochiral groups, and since no ster-
eoassignments were made (and the assignment-swapping protocol within XPLOR-NIH for deriving stereoassignments indirectly
during the structure calculation itself was not applied), all constraints involving protons within such groups were converted to group
constraints (by using wildcards such as HB*). All lower bounds were set to zero. Structures were calculated from polypeptide chains
with randomized f and c torsion angles using a two-stage simulated annealing protocol within the program XPLOR-NIH as follows:
The first stage comprised Powell energy minimization (500 steps), dynamics at 1,000 K (20,000 steps), increase of the van der Waals
force constant during tilting of the NOE potential function asymptote (4,000 steps), switching to a square-well NOE function then
cooling to 300 K in 2,000 step cycles, and final Powell minimization (1,000 steps); the second stage comprised Powell minimization
(500 steps), increasing dihedral force constant during 4,000 step cycles of dynamics at 1,000 K (with a strong van der Waals force
constant and square-well NOE potential function), cooling to 300 K in 1,000 step cycles, and 2,000 steps of final Powell minimization.
All fifty structures calculated in XPLOR-NIH were finally subjected to a further stage of refinement using a full force field and an
implicit water-solvent model as implemented in the program AMBER 11 (Case et al., 2005). Calculations comprised initial minimiza-
tion (200 steps steepest descent then 1800 steps conjugate gradient), then two rounds of 20ps of simulated annealing (each
comprising 5000x1fs-steps heating from 0 - 500K; 13000x1fs-steps cooling to 100K; 2000x1fs-steps cooling to 0K) and final mini-
mization (200 steps steepest descent then 1800 steps conjugate gradient). The experimental distance restraints were applied
throughout, and force constants for the distance restraints were increased linearly during the simulated annealing to a final value
of 20 kcal mol-1A˚-2. Implicit solvent representation using the generalized Born method was employed throughout (igb=1), and Lang-
vin temperature control was used (ntt=3; gamma_ln=5). The 30 structures with lowest AMBER energies were selected for deposition.
There is a previously published NMR structure of NECAP 1-133 (pdb 1TQZ) (Ritter et al., 2007), but this differs somewhat from our
own free protein structure (rmsd between the lowest energy structures of each ensemble over N, Ca, C’ atoms for residues 7-131 is
4.82A˚; Figures S6C and S6D); consequently we chose not to use 1TQZ in our comparison between the free and bound states of NE-
CAP 1-133, so as to ensure that any differences identified were genuinely due to peptide binding. The topology of the secondary
structural elements in 1TQZ is the same as for the structure of NECAP 1-133 reported here, but at a more detailed level differences
include i) 1 TQZ has Ala at position 3 and Ile at position 55, whereas the samples used here have Thr 3 and Thr 55, ii) proline 78 is
clearly in the cis conformation (Dd13C(b-g) = 8.82ppm; strong NOE cross peak seen from Tyr 77 Ha to Pro 78 Ha but not to Pro
78 Hd2/3) but is modelled as trans in 1TQZ; iii) 1TQZ results from analysis of samples in a different buffer (25mM sodium phosphate,
75mMNaCl, 0.5mMEDTA and 3mMDTT, pH 7.2), and iv) the number of medium and long-range NOE-derived restraints used during
calculation of 1TQZ was rather low (148). Statistics from the structure calculations are presented in Table S4.
Liposome-Based Surface Plasmon Resonance Assays
Production of Liposomes
Peptides derived from the cytoplasmic domains of TGN 38 (CKVTRRPKASDYQRL) and phosphorylated CD4 (CHRRRQAERM(SP)
QIKRLLSEK) were synthesized by GenScript, with an additional amino-terminal cysteine. These peptides were then conjugated to
a 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (Avanti, USA) as described in (Ho¨ning
et al., 2005; Jackson et al., 2010). Resulting lipopeptides were then used for synthesis of liposomes containing sorting signals.
The liposomes were synthesized by rehydration of a desired lipid film in 0.3 M sucrose followed by sedimentation, resuspension in
20 mM HEPES, pH 7.4, and extrusion through a 100 nmmembrane. The ‘‘basic’’ liposomes contained 80% pig-brain-derived phos-
phatidylcholine and 20% phosphatidylethanolamine. Complex liposomes were prepared by substituting PCwith 2% of a lipid-linked
peptide and/or 4% of a phosphoinositide PI(4,5)P2.
Biosensor Experiments
All SPR experiments were run on BIAcore T200 machine (BIAcore AB, Sweden) with 10 mM Tris pH 8.7, 250 mM NaCl, 1 mM DTT
used as a running buffer. Liposomes were deposited on a surface of an L1 biosensor to generate a ‘‘membranemimic’’. In order to do
so, the system was equilibrated in the running buffer and the surface of the L1 sensor was primed with three 60 sec injections of
20mMCHAPS. This was followed by sequential injections of the liposomes (at 0.25mMfinal concentration) aiming to reach the target
of 7000 RU in each flow cell. Subsequently, the loosely bound liposomes were removed by two pulse injections of 50 mM sodium
hydroxide for 5 s each. The entire procedure was run at 10 ml/min. The affinities of the AP2 cores and Pcores to the immobilised li-
posomes were then measured at a flow rate of 30 ml/min. The proteins were injected at concentrations ranging from 50 nM to 50 mM
for 90 sec (association) followed by a buffer flow for 510 sec (dissociation). The liposome surfaces were then regenerated by a 10 s
pulse injection of 50mMNaOH. In all analyses, the background signal from the protein binding to the basic liposomes (80%PC, 20%
PE) measured at flow cell 1 was subtracted from the binding to the complex liposome species.
SPR Data Analysis
The kinetic analysis of Pcore and core binding to the liposomes was then carried out. None of the systems studied gave single expo-
nential kinetics. The association and dissociation phases were therefore routinely analysed using a double exponential function,
which returned reaction amplitudes for the fast and slow components of each phase. Reaction amplitudes for the fast and slow com-
ponents of the dissociation phases were generally more reproducible than those for the association phases. These data were there-
fore used to obtain apparent equilibrium dissociation constants associatedwith the fast and slow components by fitting the change in
amplitude with protein concentration using a simple 1:1 binding model. The results of the analysis are shown in Figure S3G and
Table S2.e6 Developmental Cell 50, 494–508.e1–e11, August 19, 2019
Isothermal Titration Microcalorimetry
Experiments were performed using a Nano ITCmachine from TA Instruments. For ITCwith peptides, PHear domains were gel filtered
into 75 mM HEPES pH 7.4, 0.25 mM TCEP. Peptides were dissolved in the same buffer. PHear domains at concentrations between
0.10 and 0.15 M were placed in the cell at 12C and peptides at concentrations between 1 and 5 mM (depending on a peptide) were
titrated in with 20 injections of 2.43 ml each separated by 2.5 minutes. For ITC withWT PHear and Pcore, the proteins were gel filtered
into 100 mM TRIS pH 8, 250 mM NaCl, 0.25 mM TCEP and experiments were carried out at 10C with between 0.05 and 0.1 mM
Pcore in the cell and with PHear domain between 2 and 3 mM being titrated in with 20 injections of 2.43 ml each separated by 2.5 mi-
nutes. A relevant syringe-solution-into-buffer blank was subtracted from all data and for constructs, which displayed measurable
binding, a minimum of three independent runs that showed clear saturation of binding were used to calculate the mean KD of the
reaction, its stoichiometry (n), and their corresponding SEM values (see Table S5). Analysis of results and final figures were carried
out using the NanoAnalyzeTM Software.
Fluorescence Anisotropy Measurements
A peptide encoding the TGN38 YxxFmotif (sequence ASDYQRL) and modified at its N-terminus with fluorescein (Sigma-Genosys)
was used in all binding experiments at a concentration of 50 nM. Various quantities of recombinant AP2 core or isolated C-m2 were
premixed with the fluorescent peptide and incubated for 10 minutes to allow the mixture to come to equilibrium. Protein / peptide
mixtures were prepared in 10 mM Tris pH 8.7, 250 mM NaCl (for AP2 core / phosphorylated AP2 core) or 20 mM HEPES pH 7.4,
500 mM NaCl (for C-m2). Fluorescence anisotropy measurements were carried out at 25

C with a Clariostar plate reader (BMG Lab-
tech) using a 482/530 nm fluorescence polarisation module. Where used, polymeric heparin (porcine, from intestinal mucosa; activity
197.0 U/mg; mean MW 15kDa; Merck) was added to 500 mM concentration, and NECAP PHear domain was added to 200 mM.
Mean fluorescence anisotropy values (3 or more measurements) were plotted against protein concentration and the curves fitted
to a single-site binding model:
F = Ff + (Fb - Ff).[L]/(Kd + [L])where F is themeasured anisotropy in amixture of free (f) and bound (b) fluorescent peptide with anisot-
ropy of Ff and Fb respectively, [L] is the pseudo-first order concentration of ‘‘ligand’’ (in this case, C-m2, AP2 or P-AP2) and Kd is the
equilibrium dissociation constant. Curves were fitted with ProFit software using the Levenberg-Marquardt algorithm. Figures S3 and
S5 shows data plots and curve fits.
In addition to C-m2, and P-AP2 core pre-incubated with heparin or with a mixture of heparin and NECAP PHear domain, binding
titrations were performed with AP2 core in the absence of heparin, resulting in only a slow linear increase in anisotropy as previously
reported (Jackson et al., 2010), indicating a background of nonspecific binding (data not shown).
GST Pull-downs and Mass Spectrometry
Interaction partners of various recombinant fusion proteins were identified after incubation brain or tissue-culture cell lysates. For
brain lysates, a single frozenmouse brain was thawed in 1ml of buffer-T (25mMTris pH 7.8, 140mMNaCl, 1mMDTT, 0.1mMAEBSF,
phosphatase inhibitors, 0,1% NP40), cut to small pieces and slowly homogenized with a glass homogenizer. The final brain lysate
was collected as the supernatant of three consecutive centrifugations (5 min/1000xg; 10 min/1,000xg and 30 min/100.000xg). Ly-
sates of tissue-cultured cells were prepared from 15 confluent dishes (15cm ø). Cells were washed with PBS, scraped off the dishes
and collected by centrifugation for 5min/500xg. The derived pellets were resuspended in 5x Vol buffer-T, incubated for 20min at 4C
and the final lysates were gained as the supernatants of two consecutive centrifugations (20min/21.000xg; 30min/100.000xg).
The following proteins were used as baits: GST (negative control), GST-Core, GST-Pcore, GST-NECAP1 PHear (residues 1-133)
and mutants of thereof (R90A, R102A, R90A/R102A). Equal amounts ( 10 mg) of GSH-bead immobilized bait proteins were incu-
bated with 1-3 mg of tissue or cell lysates in a total volume of 1 ml buffer-T and incubated 1h/4C. Afterwards, beads with bound
proteins were collected by centrifugation for 5min / 500xg. Lysates were removed and beads were processed for mass spectrom-
etry-based identification of bound proteins after washing 2x with buffer-T and 2x buffer without detergent.
To test binding of full-length NECAP1 and NECAP1 PHear (1-133) to core and Pcore, they were expressed as N-terminally GST-
tagged fusion proteins and immobilized to GSH-beads. An equivalent of 6mg was incubated with 20mg of core or Pcore for 15min at
RT in buffer T. Subsequently, the beads were collected by centrifugation and washed 1x with buffer T and 1x with buffer T without
detergent. Bead-bound proteins were resolved by SDS-PAGE, followed by western blotting and detection of the AP2 m-subunit.
Binding of full-length NECAP1 andNECAP1PHear (1-133) to various AP2 species was also tested in buffer B (250mMNaCl, 20mM
TRIS pH 8, 0.1 % NP40, 1mM DTT, 0.1mM AEBSF,) following the same protocol but with proteins detected with Coomassie stain. In
such experiments NECAP1 constructs were used as baits and AP2 core, AP2 Pcore, AP2 core or Pcore in presence of 0.5 mM or
5mMCSFFEDNFPE peptide (derived from amphiphysin, containing the FxDxFmotif), AP2 a-FLcore, and AP2 a-FLPcorewere preys.
To assay the binding to phospho- / non-phospho versions of GST-m2(122-171) and GST-m2(149-163), NECAPwere expressed and iso-
lated as N-terminally 6His-tagged fusion proteins and immobilized to NiNTA beads. Details of incubation and washing were as above
and binding was detected after SDS-PAGE and Coomassie staining.
Beads from pulldown experiments with bound proteins were resuspended in 25ml 50 mM Tris pH 7.5, 2M Urea, 1 mM DTT, 150 ng
Trypsin and incubate for 30 min at RT. Then, 50 ml of 50 mM Tris pH 7.5, 2M Urea, 50 mM Chloracetamid were added followed by
centrifugation (3 min / 500xg). This supernatant and a second supernatant derived from an additional washing with Chloracetamid
containing buffer were combined and incubated overnight at RT. Digestion was then terminated by addition of 1ml TFA. The derived
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For LC/MS analysis, samples were analyzed on a Q-Exactive Plus mass spectrometer (Thermo Scientific) coupled to an EASY nLC
1000 UPLC (Thermo Scientific). Peptides were loaded with 0.1% formic acid in water (solvent A) onto a self-packed Poroshell column
(50 cm 3 75 mm, 2.7 mm sized EC120 C18, Agilent) and separated at a flow rate of 250 nL/min using the following gradient: 3 - 5%
solvent B (0.1% formic acid in 80%acetonitrile) within 1min, 5-30% solvent Bwithin 40min, 30-50% solvent Bwithin 8min, followed
by washing with 95 % solvent B for 10 min. The mass spectrometer was operated in data-dependent acquisition mode. The MS1
survey scan was acquired from 300-1750 m/z at a resolution of 70.000. The top 10 most abundant peptides were isolated within
a 1.8 Th window and subjected to higher energy collisional dissociation fragmentation at a normalized collision energy of 27%.
The automatic gain control target was set to 5e5 charges, allowing a maximum injection time of 110 ms. Product ions were detected
in the Orbitrap at a resolution of 35.000. Precursors were dynamically excluded for 20 s.
All mass spectrometric raw data were processed with Maxquant (version 1.5.3.8) using default parameters. Briefly, MS2 spectra
were searched against a FASTA database constructed from reviewed and unreviewed human sequences extracted from Uniprot
(downloaded at: Sept 2018). A list of common contaminants was included in the searches. False discovery rates on protein and
PSM level were estimated by the target-decoy approach to 1% (Protein FDR) and 1% (PSM FDR) respectively. The minimal peptide
length was set to 7 amino acids and carbamidomethylation at cysteine residues was considered as a fixed modification. Oxidation
(M) and Acetyl (Protein N-term) were included as variable modifications. The match-between runs option was enabled.
After mass spectrometry-based identification of proteins captured in a pulldown experiment, we first eliminated any hit (identified
by the presence of one or more peptides) that was captured by GST, which served as a negative bait control. In a second step we
deleted any low abundance protein (identified by the presence of two or less peptides) from the list, as wewished to focus only on the
most prominent binding partners. For the identification of proteins binding specifically to Pcore, we eliminated any protein hit (more
than a single peptide present) that bound to GST and/or Core. The remaining lists of proteins were ranked from the top downwards
based on the iBAQ values of any hit. Results are summarised in Tables S3, S6, and S7.
m2NAK– and m2T156D Retroviral Constructs
The m2NAK and m2T156D sequences were generated using standard site-directed mutagenesis in the m2 cDNA inserted in retroviral
bicistronic IRES-BFP vector PMIB6 previously described (Kadlecova et al., 2017). m2NAK sequence contained Q154 to S and G157 to
A mutations.
mRuby2-Flag- NECAP1 and mRuby2-Flag- NECAP2 Retroviral Constructs
Gene sequences of human NECAP1 and NECAP2 (RefSeq NM_015509, and NM_018090), N-terminally fused with mRuby2-Flag-
GGGS and flanked by Not1 and Sal1 were custom synthesized by IDT. Standard restriction cloning techniques were used for inser-
tion into retroviral vector PMIB6.
mRuby2-Flag -SNX9
The cDNAof SNX9, with a sequence corresponding to NM_016224.4, was a gift of FolmaBuss, CIMR. The SNX9 construct wasmade
usingGibson AssemblyMasterMix (E2611, NewEngland BioLabs) to introducemRuby2-Flag-GGGS at the N-terminus together with
NotI and SalI restriction sites. The cDNA was inserted into PMIB6 using standard restriction cloning techniques.
Retrovirus Preparation
Retrovirus particles were generated by co-transfecting HEK 293T cells in the presence of polybrene (Merck) with 3 plasmids coding
for Gag-Pol, VSV-G and the retroviral expression constructs in PMIB6. FACS was used to sort population of cells expressing fluo-
rescent marker as described below.
RPE Cell Lines Stably Expressing m2NAK– and m2T156D
After retrovirus infection, cohorts of cells expressing various levels of mutant m2 subunits were sorted by FACS based on BFP inten-
sity. The levels of expression of m2 subunit within each stable cohort was validated by western blotting using the anti- m2-antibody
(AP50, BD Bioscience). The cell population with the expression levels closest to the endogenous m2-adaptin was selected for further
experiments. The absence of phosphorylation in m2NAK- cell line was tested with three different anti-m2pT156 antibodies: rabbit
monoclonal ab109397 (Abcam), rabbit monoclonal D4F3 (Cell Signalling), rabbit polyclonal #3843 (Cell Signalling).
RPE Cell Lines Stably Expressing mRuby2-Flag-NECAP1, mRuby2-flag- NECAP2 and mRuby2-flag-SNX9
Cohorts of RPE cells expressing several different levels of NECAP1, NECAP2 or SNX9 were sorted by FACS based on mRuby2 fluo-
rescent intensity. Anti-NECAP antibody (SAB1101485, SIGMA) or anti-SNX9 antibody (Sigma, HPA031410) was used to detect
expression levels closest to the endogenous protein by western blotting.
siRNA Transfection
siRNA mediated depletion of endogeneous m2, NECAP1 or NECAP2 was carried out with 3 rounds of siRNA transfection at 12, 36,
and 60h after plating. The experiments were performed on the fifth day. The target sequences for siRNAswere located at 3’UTR of the
genes. The sequences were as following: NECAP1: GCTTAAAAGGCCAGCGTCT, NECAP2: GTAAATTGGCACCGTGTCA. Separate
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NECAP2: GTGGAGAGTGTGACGGATT. m2 siRNA sequencewas CCAAAGGCCAGUAAUGGAU. Targeting siRNA together with non-
targeting control sequence was acquired from Dharmacon ON-TARGETplus Human siRNA series.
Triple Color Immunofluorescence Microscopy
Immunofluorescence of m2pT156-AP2-CLCegfp, m2pT156-CLCegfp-NECAP and AP2-CLCegfp-NECAP were prepared to decipher
the quantity and distribution relationship between the stated components. Parental cell lines expressing CLCegfp alone or in com-
bination with NECAP1-mRuby2 were grown overnight in 6-well plates on a glass cover slips at a quantity of 1x105 cells. Cells were
fixedwithmethanol at -20C for 45s and incubated with 2%BSA for 30min at 4C. Cells were either incubated for 3h at 10mMof LP or
in vehicle control (0.1% (v/v) DMSO) prior to the fixation. Cells were incubated with a rabbit monoclonal anti- m2pT156 antibody
(1:500, D4F3, Cell Signalling) or anti-AP2a antibody AP6 to stain for total AP2 at 4C overnight. Cells were washed three times
with PBS and further incubated with appropriate AlexaFluor labeled secondary antibodies (Life Technologies) for 1h. After three
washes with PBS the cover slips were mounted in stainless-steel chamber and imaged in PBS on Zeiss Elyra microscope in TIRF
mode at room temperature.
Dual Color Immunofluorescence with Transferrin Receptor
To assess the dependency of cargo colocalization to CCPs on m2T156 phosphorylation, cells were pretreated with 10mM of LP or in
vehicle control (0.1% (v/v) DMSO) for 3h. Cells were chilled at 4C and pre-chilled solution of mouse monoclonal anti-Tfr antibody
OKT9 (Bio-X-cell) containing also LP was added to the wells at a final concentration 4mg/mL. Cells were incubated at 4C for
30min, fixed and permeabilized using PFA and 0.1% saponin for 20 min and processed for TIRFM as described above.
Quantification of Signal Distribution and Colocalization in Immunofluorescence Images
Immunofluorescence images of control cells, m2NAK cells or cells exposed to NAK inhibitors were imaged under identical conditions,
and post-acquisition image processing and analysis was also identical for all conditions to allow for direct comparison. The spatial
relationship and the degree of colocalization between signals in dual-colour or triple-colour immunofluorescence images were
analyzed using Matlab (MathWorks, Natick, MA, USA). The aim of the analysis was to characterize the recruitment of the CCP com-
ponents (AP2, NECAP, CLCegfp and Tfr) in relation to AP2 phosphorylation. To that end we compared the results of the analysis
for immunofluorescence images acquired with control cells and cells treated with NAK inhibitors or m2NAK cells. We adapted
CMEanalysis software (Aguet et al., 2013) and the analysis consisted of following steps, each described in detail below: object detec-
tion, intensity normalization and calculation of colocalization and distribution statistics.
Object Detection
EGFP-CLCa, AP2, P-AP2, TfR or NECAP signals were detected independently for the two or three fluorescence channels using the
spot detection algorithms(Aguet et al., 2013; Zaritsky et al., 2017) (Aguet et al., 2013). Clathrin-coated structures (CCS) were
assumed to be diffraction-limited, producing a signal that is well approximated by 2D Gaussian function in TIRF microscopy. Fluo-
rescence signals were identified by numerically fitting a 2D Gaussian at candidate locations, and statistically testing the amplitude
against the residual background noise estimated at each location. For the purpose of the statistical and quantitative analysis themain
channel was denominated as a ‘‘master’’ and the dependent channels were denoted as ‘‘slaves’’. The location of the detected signal
in the master channel was used to determine the search radius for the detection of the overlapping signal in the dependent slave
channel.
Intensity Normalization
CCP intensities from individual cells were normalized similarly as in CMEanalysis software. It consisted of selecting the median cu-
mulative distribution of CCS intensities as a reference distribution and estimation of a scaling factor for each cell that minimizes the
mean squared error between the scaled distribution and that of the reference.
Calculation of Colocalization and Distribution Statistics and Data Representation
Correlation of Signal Intensity for a Pair of CCP Components
Pearson correlation coefficient (PCC) (Zaritsky et al., 2017) for the paired intensity value between master channel and slave channel
was calculated in all detections in respective master channel for each cell and the results are averaged from 3 independent exper-
iments, each containing at least 20 cells and represented as mean value +/- SD. Single cell masks were manually annotated in each
field of view and quantification of colocalization was performed as described in the previous paragraph.
Determining the Proportion of CCPs Containing Significant Signal
PCCs capture only linear relations of the paired intensity values (Zaritsky et al., 2017). To have a better understanding of the mutual
relation of fluorescence intensities of paired signals, we calculated a function of proportions. This function describes evolution of the
number of detections in master channel that contain significant signal in the slave channel. Significance of the signal was determined
by a threshold, which was set identically for all measured conditions to allow for direct comparison between conditions.
Detections in master channel were divided into bins based on their fluorescence intensity. Non-overlapping intensity intervals of
bins were estimated in such a way that the bins contain approximately the same number of detected spots. The proportion of spots in
each bin that were above the given significance level in the slave channel was plotted as a function of the bin intensity. This function
thus depicts the impact of the appearance of the signal in slave channel on the amount of fluorescence intensity in the master
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Single Colour and Dual Colour Live Cell TIRF Microscopy and Data Analysis
RPE cells expressing EGFP-CLCa and either NECAP1-mRuby2, NECAP2-mRuby2 or SNX9-mRuby2 were imaged using a Zeiss
Elyra microscope, appended with a 100 3 1.49 NA Apo TIRF objective (Zeiss) and mounted on inverted microscope equipped
with the Definite Focus System. Time-lapse image sequences from different cells were acquired at a frame rate of 0.5 frame/s using
a sCMOS camera with 6.45 3 6.45 mm2 pixels (Photometrics). Similarly, near simultaneous 2-channel (488nm/561nm TIRF) videos
were acquired at 0.5 frame/s. Cells in control experiments, m2NAK cells, or cells exposed to NAK inhibitors were acquired under iden-
tical illumination and acquisition conditions. Quantitative analysis to distinguish bona fide CCPs and to measure CCP initiation rates,
lifetime distributions, and density of static structures was performed using CMEAnalysis software (Aguet et al., 2013; Kadlecova
et al., 2017; Loerke et al., 2011). On minimum 10 control and 10 treated cells consisted a single independent biological repeat
and 3 biological repeats were conducted. Single cell masks were manually annotated in each field of view. The analysis reported
in this work focuses on 2 types of clathrin structures found at the plasmamembrane – bona fide CCPs and persistent clathrin coated
structures. To identify bona fide CCPs (i.e. those structures undergoing successful growth after nucleation followed by maturation
phase) we used method described in (Aguet et al., 2013) that is based on intensity thresholding of trajectories. The thresholding
step discriminated between transient coat assemblies and bona fide CCP. The results of CCP lifetime dynamics are either presented
in the formof lifetime distributions or average EGFP-CLCa (in green) andNECAP/SNX9 (in red) fluorescence intensity traces in lifetime
cohorts. Persistent clathrin coated structures, are excluded from this lifetime analysis and analysed and represented separately.
Persistent structures are defined as present throughout the entire acquisition. The significance of the results was determined with
a one-tailed, two-sample t-test.
Calculation of Time of Maximum SNX9 Recruitment Rates and NECAP Maximum Intensity
NECAP-mRuby2 averaged intensity values for individual cohorts (sampled in 2s interval) were smoothed by Gaussian kernel (stan-
dard deviation 1.2) and amaximumwas found with subsample precision using cubic interpolation. SNX9-mRuby2 maximum recruit-
ment rate was computed in the same way, as a maximum of intensity differences (central difference was used). Averaged intensity
valueswere calculated from videos acquiredwithminimum10 cells in 2 separate experiments using SNX9-mRuby2 cells or NECAP1-
mRuby2 RPE cells.
Transferrin Receptor Internalization
Transferrin receptor (Tfn) internalization at 37C experiments were performed using anti-TfnRmAb (OKT9, Bio-X-Cell). Cell lines were
grown overnight in 96-well plates at a density of 2.0 3 104 cells/well. Plates were incubated with 4 mg/ml of OKT-9 at 37C for the
indicated time points. Cells were then immediately cooled down (4C) to arrest internalization. Following a washing step to remove
unbound ligand (13 PBS, 4C), the remaining surface-bound ligand was removed from the cells by an acid wash step (5 3, 0.2 M
acetic acid, 0.2 M NaCl, pH 2.5, 4C). Cells were washed with PBS and then fixed in 4% PFA in PBS for 20 min and further permea-
bilized with 0.1% Triton X-100/PBS for 10 min. Internalized OKT-9 was assessed using a goat anti-mouse HRP-conjugated antibody
(Life Technologies), further developed with OPD (P1536, Sigma-Aldrich), and the reaction was stopped by using 2M H2SO4. The
absorbance was read at 490 nm with BMG CLARIOstar Microplate Reader.
Internalization efficiency measured upon acute treatment with LP inhibitor was carried out in the presence of 10mM LP with cells
pre-incubated with LP for 3h. Internalization experiments measured in m2NAK- cells, NECAP1-WT or NECAP1-R90A were carried out
after siRNA mediated knockdown of endogenous protein (see above). Results of individual independent experiments (n=3) were
pooled, averaged and presented as mean±SD, n=3. The statistical significance was analyzed by two-tailed, unpaired t-test.
Immunoprecipitation and Immunoblot Analyses
For immunoprecipitation experiments, cells were grown to 80% confluency in 15cm dishes. NAK kinase inhibitor 1, LP-935509 and
NAK kinase inhibitor 2 (Cas No1093222-27-5) were reconstituted in DMSO as a stock solution at 10mM and used at 1/1000. Cells
were incubated in fresh medium containing 10uM solution of either inhibitor or 0.1 v/v% DMSO for 3h. Media was removed from
the dishes and cells were washed three times with ice cold PBS. Cells were scraped and then solubilized in 0.1% NP40 lysis buffer
using 10x passage through a 25G needle, insoluble debris was removed by centrifugation of the lysates at 10,0003 g for 10 min. An
equal amount of each protein lysate was incubatedwith anti-AP2a antibody AP6 conjugated to protein G-Sepharose beads overnight
at 4C. The immune complexes were analyzed by Western blot with rabbit anti-AP2- m2 (Abcam, (ab75995)), anti-AP2a (#AC1-M11,
Pierce), Anti AP2-m2 pT156 D4F3 (Cell Signalling), SNX9 (Sigma, HPA031410), anti-NECAP 1/2 (SAB1101485, SIGMA).
SILAC
RPE cells were grown in custom-made DMEM (minus arginine and lysine; Invitrogen) supplemented with 10% dialyzed fetal calf
serum (Invitrogen). l-arginine (84 mg/ml;) and l-lysine (146 mg/ml lysine; Sigma-Aldrich) were added to the ‘‘light’’ media, while and
l-arginine 13C/15N and l-lysine 13C/15N (Cambridge Isotope Laboratory) to the ‘‘heavy’’ media at the same concentrations. The
amino acid concentrations are based on the formula for normal DMEM (Invitrogen). Once prepared, the SILAC media was mixed
and filtered through a 0.22-mm filter (Millipore) and stored at 4C. RPE cells were passaged in SILAC media for at least 2 weeks
(or 5 cells doublings) before harvesting to ensure complete incorporation of isotopic amino acids. Cells were harvested for heavy
amino acid incorporation check and immunoprecipitation. Immunoprecipitation was carried out as described above using RPE
cell lysate prepared from three 15cm dishes for each condition. 100uL of G-Sepharose beads conjugated to 500 ug of anti-AP2a
antibody AP6 were used for each immunoprecipitation. After incubation at 4C O/N beads were rapidly washed with lysis buffer
at 4C three times. We followed manufacturer’s instructions for Trypsin-LysC mix digestion (Promega). Beads from both conditions
were combined and incubated with aqueous solution of dithiothreitol at a final concentration of 5 mM at room temperature for 1h.
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immunoprecipitated proteins were digested in 200 mL of buffer containing 4M urea, 50 mM Tris-HCl pH 7.5 and 5 mg/mL Trypsin and
LysCmix at 37C overnight. After the initial digestion, the samples were centrifuged for 5 min at 14 000 rpm and the supernatant was
collected in a clean tube separate from the beads. Beads were washed twice in 100 mL of urea buffer and the supernatants were
pooled. Digestion with fresh enzymemix continued at 37C for additional 12h at 2M urea buffer. In the next step samples were treated
with trifluoroacetic acid (TFA) to stop digestion. We followed previously published protocol (Borner and Fielding, 2014) to desalt the
tryptic peptides with stage tips with SDB–RPS filler material (Empore material 3M).
LC-MS Analysis
Peptides were eluted from SDB-RPS tips with 30 ml of 5 % (w/v) ammonium hydroxide in 80% acetonitrile (ACN) and dried a
speed vac.
All samples were analyzed on a Q-Exactive Plus (Thermo Scientific) mass spectrometer that was coupled to an EASY nLC
1000 UPLC (Thermo Scientific). After resuspension in 10 ml 5% formic acid, 2% ACN the peptides were loaded with 8 ml solvent A
(0.1% formic acid in water) onto an in-house packed analytical column (50 cm 3 75 mm I.D., filled with 2.7 mm Poroshell EC120
C18, Agilent). Peptides were separated at a constant flow rate of 250 nL/min using the following gradient: 3 - 5% solvent B (0.1%
formic acid in 80 % ACN) within 1 min, 5-30% solvent B within 40 min, 30-50% solvent B within 8 min, followed by washing with
95 % solvent B for 10 min. The mass spectrometer was operated in data-dependent acquisition mode.
TheMS1 survey scan was acquired from 300-1750m/z at a resolution of 70.000. The top 10most abundant peptides were isolated
within a 1.8 Th window and subjected to HCD fragmentation at normalized collision energy of 27%. The AGC target was set to 5e5
charges, allowing a maximum injection time of 110 ms. Product ions were detected in the Orbitrap at a resolution of 35.000. Precur-
sors were dynamically excluded for 20 s.
Database Search
All mass spectrometric raw data were processed with Maxquant (version 1.5.3.8) using default parameters. Briefly, MS2 spectra
were searched against a fasta database constructed from reviewed and unreviewed human sequences extracted from Uniprot
(downloaded at: 16.6.2017). TheMaxquant default list of common contaminants was included in the searches. False discovery rates
on protein and PSM level were estimated by the target-decoy approach to 1% (Protein FDR) and 1% (PSMFDR) respectively. Trypsin
was chosen as the digestion enzyme with a maximum of 2 missed cleavages. The minimal peptide length was set to 7 amino acids
and carbamidomethylation at cysteine residues was considered as a fixed modification. Oxidation (M) and Acetyl (Protein N-term)
were included as variable modifications. Thematch-between runs option was enabled. The LFQ algorithm implemented inMaxquant
was used for label free quantification. For SILAC quantification (Arg10 and Lys8) multiplicity was set to 2 and the re-quantify option
was enabled. Statistical analyses, data transformation, and filtering were performed in Perseus 1.6.1.1 and results were visualized
using the same software. Identifications were filtered by removing reverse hits, matches based on modified peptides only, and com-
mon contaminants (‘standard filtering’).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification analysis for the all the data presented in this manuscript have already been detailed in the STAR Methods section
above, associated with each experiment, as well as in the figure legends. In all instances, data were obtained from at least 3 inde-
pendent replicates so that meaningful SDs could be quoted as defined in the figure legends. Datasets were tested for normal distri-
bution and depending on outcome, populationswere tested for significant differences using the two-tailed, unpaired t-test performed
in GraphPad Prism6.
DATA AND CODE AVAILABILITY
The data sets generated during this study are available as follows:
Structure coordinates have been deposited on the PDB with the accession codes 6QH5 closed Pcore, 6QH6 open+ core, 6QH7
open+ Pcore and NECAP PHear+m2phosphopeptide 6RH6 and PHear 6RH5.
Mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identifier PXD013468.
Live cell imaging datasets and immunofluorescence data sets are available from corresponding author ZK on request.Developmental Cell 50, 494–508.e1–e11, August 19, 2019 e11
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Figure	 S1	 (related	 to	 Figure	 1).	 µT156	 phosphorylation	 can	 be	 acutely	
inhibited	with	specific	small-molecular	inhibitors.			
A	Schematic	of	heterotetrameric	AP2	complex.	
B	 Immunoblots	 of	 AP2	µ2	 subunits	 using	 cell	 lysates	 obtained	 from	RPE	 cells	treated	 with	 vehicle	 control	 DMSO	 (at	 equal	 volume	 as	 inhibitor	 solution,	 i.e.	0,1%	v/v),	LP	or	inhibitor	AAK1	(CAS	1093222-27-5)	for	3h	at	10uM.		
C	 Conservative	 mutations	 in	 mouse	 µ2-adaptin	 sequence	 to	 generated	 µ2NAK-construct.	Mutations	are	targeting	conserved	residues	to	ablate	NAK	binding	to	
µ2	adaptin.	
D	Immunoblots	of	AP2	µ2wt,	µ2NAK-,	µ2T156D	subunits	expression	in	RPE	cells.	The	variants	 of	 µ2-adaptins	 (that	 also	 harboured	 silent	 mutations	 to	 render	 them	siRNA-resistant)	 were	 stably	 expressed	 in	 EGFP-CLCa	 expressing	 RPE	 cells	 by	retrovirus	 infection.	Cells	 expressing	near-endogenous	 levels	of	 the	 introduced	subunits	were	 selected	by	 fluorescence-activated	 cell	 sorting,	using	an	 internal	ribosome	entry	segment-expressed	blue	fluorescent	protein	(BFP).	The	selected	population	was	 used	 for	 further	 experiments.	 Prior	 to	 experiments	 cells	 were	treated	 with	 µ2-adaptin	 siRNA	 to	 silence	 the	 endogenous	 µ2-adaptin.	 The	absence	 of	 phosphorylation	 was	 verified	 with	 3	 different	 antibodies	that	specifically	 recognize	the	 phosphorylated	 µ2 linker	 (polyclonal	 Ab	 #3843	and	rabbit	monoclonal	D4F3	and	Ab	#7399	ab109397).	
E	 Time	 course	 of	 TfR	 uptake	 in	 cells	 treated	with	DMSO,	 inhibitor	 AAK1	 (CAS	1093222-27-5)	or	LP	for	3h	at	10uM.	Data	are	represented	as	a	mean	with	S.D.	(n	=	3).		
F	Time	course	of	TfR	uptake	in	µ2NAK-	and	µ2NAK-	treated	with	LP	for	3h	at	10uM.	Two-tailed	Student’s	t-tests	were	used	to	assess	statistical	significance.	*P	<	0.05.	
G	Bar	graphs	represent	 the	quantification	of	 the	membrane	distribution	of	AP2	(red)	 or	 P-AP2	 (blue)	 in	 CCPs	 of	 LP	 treated	 cells.	 The	 bar	 height	 displays	 the	proportion	of	CCPs	(detected	in	EGFP-CLCa	channel)	that	contain	significant	AP2	or	P-AP2	signal	in	the	same	position	plotted	as	a	function	of	EGFP-CLCa	signal	(x-axis).		H	Averaged	total	lifetime	in	5th,	25th,	50th,	75th,	95th	CCP	percentile	for	
μ2NAK-	cells	and	cells	treated	with	LP	in	comparison	to	control	cells,	n	=	18	cells,	**P	≤	0.01,	****P	≤	0.0001.		
	
Figure	S2	(related	to	Figure	2).	A	new	open+	conformation	for	cargo-bound	
AP2	in	both	µ2T156phosphorylated	and	unphosphorylated	forms		
A-C	Enlargements	of	functionally	important	regions	with	subunits	coloured	as	in	figure	 2,	 unrefined	 2mFo-DFc	 electron	 density	 shown	 in	 grey	 and	 difference	density	(always	contoured	at	3	sigma)	in	red	(negative)	and	green	(positive):	A	shows	 unambiguous	 Cµ2	 positioning	 after	 first,	 partial	molecular	 replacement	solution	 (unrefined	 2mFo-DFc	 map	 contoured	 at	 1.5	 sigma)	 B	 YxxΦ	 cargo	peptide	(unrefined	2mFo-DFc	map	clipped	to	3Å	around	peptide,	contoured	at	1	sigma)	 and	C	 dileucine	 cargo	peptide	 (unrefined	2mFo-DFc	map	 clipped	 to	 3Å	around	peptide,	contoured	at	0.5	sigma).	
D	 Highlighted	 important	 regions	 of	 the	 AP2	 Pcore	 in	 the	 open+	 conformation	with	 subunits	 coloured	 as	 in	main	 Figure	 2.	 Views	 perpendicular	 to	 (top)	 and	through	(middle	and	bottom)	the	plasma	membrane;	previously	established	and	proposed	 PtdIns4,5P2–binding	 	 residues	 on	 the	 AP2	 Pcore	 in	 the	 open+	conformation	 highlighted	 in	 the	 bottom	 panel	 (with	 all	 residues	 coloured	according	 to	 their	 electrostatic	 potential:	 negatively-charged	 ones	 in	 red,	positively	in	blue).		
	
	
	
Figure	S3	(related	to	Figure	3).	Comparison	between	the	open+	and	other	
AP2	Pcore	and	core	conformations.	
	
A	Structure	of	the	AP2	Pcore	in	its	closed	conformation	with	refined	2mFo-DFc	electron	 density	 (contoured	 at	 1.5	 sigma)	 and	 all	 the	 subunits	 coloured	 as	 in	main	Figure	2.	PtdIns4,5P2-analogue	IP6	is	shown	in	brown.		
B.	Comparison	of	the	AP2	Pcore	(coloured	as	before)	and	AP2	core	(grey)	in	their	closed	conformations.	
C.	 Structure	of	 the	AP2	core	 in	 its	open+	conformation	with	 refined	2mFo-DFc	electron	 density	 (contoured	 at	 0.4	 sigma)	 and	 all	 the	 subunits	 coloured	 as	 in	main	Figure	2.		
D	Comparison	of	the	open+	(coloured	as	before)	and	open	(grey)	conformations	of	the	AP2	core.	
E	Comparison	of	the	open+	(coloured	as	before)	and	closed	(grey)	conformations	of	the	AP2	core.	
F	Comparison	of	the	open+	(coloured	as	before)	and	closed	(grey)	conformations	of	the	AP2	Pcore.	
G	 Liposome-based	 SPR	 broken	 down	 into	 fast	 and	 slow	 processes	 (shown	independently)	 for	 unphosphorylated	 and	 µ2T156-phosphorylated	 AP2	 cores	for	 PtdIns4,5P2	 membranes	 +/-	 YxxΦ	 or	 dileucine	 cargo	 measured	 at	 AP2	concentrations	between	0	and	20	µM.	
H	Fluorescence	anisotropy	equilibrium	binding	curves.	Comparison	of	P-AP2	and	AP2	core	activated	by	pre-incubation	with	heparin.	Fluorescence	anisotropy	was	measured	for	varying	pseudo-first	order	concentrations	of	protein	(as	indicated)	mixed	 with	 fluorescent	 YxxΦ	 peptide	 as	 described.	 Means	 of	 three	 or	 more	measurements	are	plotted.	Standard	error	on	the	mean	is	omitted	for	clarity	but	typically	 was	 in	 the	 region	 of	 1%	 of	 the	 reported	 anisotropy.	 Curve	 fits	 are	shown	(solid	line,	AP2	with	heparin;	dashed	line,	P-AP2	with	heparin).	KD	values	estimated	from	curve	fits	were	similar	(8.6µM	±	0.7µM	for	AP2,	7.8µM	±	0.3µM	for	P-AP2).	
	
		
Figure	S4	(related	to	Figure	4).	NECAP	interacts	with	P-AP2.	
A	and	B	Domain	structure	(A)	and	sequence	(B)	of	Human	NECAP1	with	PHear	domain	boxed	in	purple	and	the	WxxF	motifs	in	black.	
C	Coomassie	blue	stained	SDS	PAGE	gel	of	proteins	used	in	E.	
D	‘GST	pull	downs’	using	the	proteins	indicated	show	that	GST	PHear	will	bind	to	phosphorylated	(Pcore	and	α-FLPcore)	but	not	unphosphorylated	(core	and	α	-FLcore)	AP2	constructs	whereas	GST	NECAP	FL	binds	to	Pcore,	α-FLcore	and	α-FLPcore.	
E.	 Thermodynamic	 parameters	 of	 the	 interactions	 between	 the	 PHear	 domain	variants	and	phospho-µ2 linker	peptides	as	well	as	Pcore	determined	by	ITC.	
F	Example	ITC	traces	(top)	and	fitted	curves	with	KDs	(bottom)	of	binding	of	wt	NECAP1	PHear	(cell)	 to	(syringe):	wt	µ2	linker	phosphopeptide	(dark	blue),	an	unrelated	 control	 threonine-phosphorylated	 peptide	 (red)	 or	 free	 phosphor-threonine	(purple).	
G.	 Immunoblot	 of	 RPE	 cells	 with	 ectopic	 expression	 of	 NECAP1-mRuby2.	NECAP1	 was	 N-terminally	 fused	 with	 fluorescent	 protein	 mRUBY2,	 FLAG-tag	sequence	 and	 flexible	 linker	 sequence	 GGGGS.	 To	 achieve	 near-endogenous	levels	 of	 stable	 expression	 of	 NECAP1-mRuby2	 we	 used	 retroviral	 expression	system	with	LTR	as	a	weak	promoter.	For	experiments	we	selected	population	of	cells	with	low	NECAP1	expression	levels	(middle	lane).	
H.	 Bar	 graphs	represent	 the	 quantification	 of	 the	 membrane	 distribution	 of	NECAP1	 in	 RPE	 cells.	 Spot	 detection	was	 carried	 out	 in	master	 channel	which	was	 either	 EGFP-CLCa	 (red	 bar	 graph),	 P-AP2	 (green	 bar	 graph)	 or	 total	 AP2	(blue	 bar	 graph).	 The	 bar	 height	 displays	 the	 proportion	 of	 spots	 (detected	 in	master	 channel)	 that	 contain	 significant	 NECAP1-mRuby2	 signal	 in	 the	 same	pixel	 position.	 The	 data	 is	 plotted	 as	 a	 function	 of	 increasing	 intensity	 in	 the	master	channel	(x-axis).		
	
	
	
Figure	 S5	 (related	 to	 Figure	 5)	 µ2T156	 phosphorylation	 causes	 NECAP		
recruitments	to	CCPs.	
A	 Representative	 intensity	 trace	 of	 EGFP-CLCa	 (upper	 panel)	 and	 NECAP1-mRuby2	 (lower	 panel)	 in	 a	 persistent	 trajectory	 spot	 in	 a	 cell	 treated	with	 LP	(3h,	 10μM).	 Such	 a	 diffraction-limited	 clathrin	 coated	 structure	 is	 present	throughout	the	entire	10min	acquisition	time.	
B	 Plots	 show	 averaged	 intensity	 traces	 for	 EGFP-CLCa	 signal	 (green)	 and	NECAP1	signal	(red)	imaged	in	cells	treated	with	pan-S,T-phosphatase	inhibitor	Calyculin	A	(5nM,	30	min),	n=20	cells.	Traces	are	shown	as	mean	±	SE	(shaded	areas)	 grouped	by	 cohorts	 according	 to	 lifetimes.	Upper	panel	 shows	 intensity	traces	 in	 NECAP1-mRuby2	 positive	 CCPs	 and	 lower	 panel	 correspond	 to	intensity	traces	in	CCPs	identified	as	NECAP1-mRuby2	negative.		
C	 Immunoblots	 showing	NECAP1	 and	NECAP2	 depletion	 by	 2	 different	 sets	 of	siRNAs	targeting	either	ORF	or	3’UTR.		Left	 panel-1st	 lane:	 RPE	 cells	 treated	 with	 non-targeting	 sirRNA	 (negative	control),	 2nd	lane:	 NECAP1	 depletion	with	 Dharmacon	ON-TARGETplus	Human	3’UTR	NECAP1	siRNA	(GCUUAAAAGGCCAGCGUCU).	3rd	 lane:	NECAP2	depletion	with	 ON-TARGETplus	 Human	 3’UTR	 NECAP2	 siRNA	(GUAAAUUGGCACCGUGUCA),	 4th	 	 lane	 simultaneous	 NECAP1	 and	 NECAP2	depletion	using	combination	of	both	using	3’UTR	siRNAs.		Right	 panel:	 -1st	 lane:	 RPE	 cells	 treated	 with	 non-targeting	 siRNA	 (negative	control),	 2nd	lane:	 NECAP1	 depletion	with	 Dharmacon	ON-TARGETplus	Human	ORF	 NECAP1	 siRNA	 (CGACCGAGUUGGAGUACGA).	 3rd	 lane:	 NECAP2	 depletion	with	 ON-TARGETplus	 Human	 ORF	 NECAP2	 siRNA	(GGUGGAGAGUGUGACGGAUU),	 4th	 lane	 simultaneous	 NECAP1	 and	 NECAP2	depletion	using	combination	of	above	mentioned	siRNA	sequences	targeting	ORF	of	NECAP1	and	NECAP2.		
D	Time	course	of	transferrin	receptor	(TfR)	internalization	at	37°C	in	cells	with	NECAP1	 depletion	 using	 ORF	 NECAP1	 sirna	 (left	 panel),	 ORF	 NECAP2	 siRNA	(middle	 panel),	 and	 simultaneous	 NECAP1	 and	 NECAP2	 depletion	 using	combination	 of	 siRNA	 sequence	 targeting	 ORF	 of	 NECAP1	 and	 NECAP2.	 Data	represent	 mean	 S.D.,	 n	 =	 3.	 Two-tailed	 Student’s	 t-tests	 were	 used	 to	 assess	statistical	significance.	**P	<	0.01.	
E	 Representative	 immunofluorescence	 images	 of	 RPE	 cells	 showing	 P-AP2,	NECAPmRuby2	and	TfR	detection.		
F	 The	 scatter	 plot	 and	 PCC	 value	 displays	 correlation	 between	 the	 intensity	values	of	NECAP1-mRuby2	and	NECAP	in	spots	detected	in	P-AP2	channel.	Plot	represent	data	from	n	=	30	cells.	
G	 Effect	 of	 PHear	 on	 affinity	 of	 heparin-activated	 Pcore	 for	 YxxΦ	 peptide	Fluorescence	 anisotropy	 was	 measured	 for	 varying	 pseudo-first	 order	concentrations	 of	 protein	 (as	 indicated)	mixed	with	 fluorescent	 YxxΦ	 peptide.	Means	of	three	or	more	measurements	are	plotted.	Standard	error	on	the	mean	is	 omitted	 for	 clarity	 but	 typically	 was	 in	 the	 region	 of	 1%	 of	 the	 reported	anisotropy.	 Curve	 fits	 are	 shown	 (solid	 line,	 P-AP2	 with	 heparin	 and	 NECAP	PHear	domain;	dashed	line,	P-AP2	with	heparin	only).	KD	values	estimated	from	curve	fits	were	similar	(7.8µM	±	0.3µM	in	the	presence	of	NECAP,	7.8µM	±	0.4µM	in	the	absence	of	NECAP.	
	
	
Figure	 S6	 (related	 to	 Figure	 6).	 Binding	 of	 NECAP1	 PHear	 to	 µ2linker	
phosphorylated	peptide	
A-D	Comparison	of	free	and	bound	structures	of	PHear	domain	of	NECAP1.	
A	 and	B	 Ensemble	overlay	of	 the	NMR	structures	of	NECAP1	PHear	domain	 in	the	free	state	(salmon	pink)	and	in	complex	with	T156-phosphorylated	µ2	linker	(NECAP1	in	cyan,	peptide	in	purple).		Fitting	was	calculated	using	the	N,	Cα and	
C'	 atoms	 of	 residues	 7-131	 in	 each	 case.	 	 Views	 A	 and	 B	 are	 related	 by	 a	 90°	rotation	about	y-axis.	
C	 and	 D	 Ensemble	 overlays	 as	 in	 A	 and	 B,	 but	 also	 including	 the	 previously	published	NMR	structure	1TQZ	(grey);	fitting	as	before.	
E	Example	ITC	traces	(top)	and	fitted	curves	with	KDs	(bottom)	of	binding	of	wt	NECAP1	PHear	(cell)	to	wt	µ2	linker	phosphopeptide	(syringe)	in	the	absence	(dark	blue)	and	presence	in	the	cell	of	2.5	mM	FxDxF	peptide	from	amphiphysin1/Bin2	(green).	Binding	of	wt	NECAP1	PHear	(cell)	to	(syringe)	V155A	µ2	linker	phosphopeptide	(gold);	and	of	R102A	PHear	(cell)	to	(syringe)	wt	µ2	linker	phosphopeptide	(purple).  
F	Coomassie	staining	of	SDS	PAGE	gel	of	pull	downs	using	GST	and	GSTPHear	of	Pcore.	Increasing	amounts	of	FxDxF	peptide	do	not	affect	the	amount	of	Pcore	bound.		
G	Immunoblots	of	RPE	cells	with	ectopic	expression	of	WT	NECAP1-mRuby2	(left)	and	R90A	mutant	version	at	near-endogenous	levels.	Populations	of	cells	with	similar	expression	levels	of	WT	NECAP1	and	R90A-NECAP1	(middle	lane,	right	panel)	were	selected.	
H	Immunoblots	of	RPE	cells	with	ectopic	expression	of	WT	or	R90A	NECAP1	with	siRNA	mediated	simultaneous	depletion	of	endogeneous	NECAP1	and	NECAP2	using	siRNA	targeting	3’UTR	of	NECAPs	(see	Fig	S5C).	
I	Comparison	of	association	of	WT	and	R90A	NECAP1	with	endogenous	AP2.		Reciprocal	co-immunoprecipitation	of	FLAG-tagged	NECAP	or	AP2α	with	either	FLAG	epitope-specific	antibody,	or	mouse	mAb	AP6	antibody.	Bar	graph	shows	quantification	of	the	respective	immunoblots	(n=1).	
J	Time	course	of	TfR	internalization	at	37°C	in	cells	with	ectopic	expression	of	WT	NECAP1-mRuby2	(left)	and	R90A	at	near-endogenous	levels	and	simultaneous	depletion	of	endogeneous	NECAP1	and	NECAP2	using	siRNA	targeting	3’UTR	of	NECAPs	(see	above).	Data	represent	mean	S.D.,	n	=	3.	Two-tailed	Student’s	t-tests	were	used	to	assess	statistical	significance.	**	P	<	0.01.	K)	Number	of	CCPs	identified	as	NECAP1mRuby2-positive	or	NECAP1mRuby2-negative	in	cells,	expressing	of	WT	NECAP1-mRuby2	or	R90A	mutant	at	near-endogenous	levels.	Values	are	mean	±	SD,	n=	17.		
	
	
	
Figure	 S7	 (related	 to	 Figure	 7).	 P-AP2:NECAP:SNX9	 interactions	 are	
important	for	CCP	maturation.	
	
A	Example	ITC	trace	(top)	and	fitted	curve	(bottom)	of	low-affinity	binding	of	wt	NECAP1	PHear	(cell)	to	wt	SNX9	linker	peptide	FLDSL	(syringe).	
B	Co-immunoprecipitation	of	SNX9	with	NECAP1-FLAG	from	lysate	of	NECAP1-mRuby2	cells	prepared	in	0.1%	NP40.		
C	NECAP1	and	SNX9	averaged	intensity	traces	from	2	independent	experiments	were	 manually	 superimposed	 for	 different	 time	 cohorts.	 	 The	 red	 dot	 on	 the	SNX9	 intensity	 trace	 (blue	 line)	 represents	 the	 calculated	 time	 of	 maximum	recruitment	 rate	 of	 SNX9.	 In	 comparison	 the	 time	 of	 maximum	 NECAP	recruitment	is	visualized	with	yellow	dot	on	NECAP	intensity	trace	(green).		The	calculation	 of	 Tmax	was	 carried	 out	 on	 intensity	 traces	 averaged	 from	 TIRFM	acquisition	 of	 at	 least	 17	 cells	 expressing	 either	 NECAP1mRuby2	 or	SNX9mRuby2.		
D	Quantification	of	western	blot	band	intensities	of	P-AP2	and	AP2α.	Results	are	represented	as	a	relative	ratio	of	P-AP2	and	AP2	signal,		n=3	.		
E	 Schematic	 diagram	 of	 relationships	 between	 unphosphorylated	 and	µ2T156	phosphorylated	AP2	cores	in	their	various	conformations	bound	and	not	bound	to	AP2’s	various	ligands.			
	 	
Supplementary	Tables	
Table	S1	(related	to	Fig.	2).		
	
Closed	AP2	Pcore	 Open+	AP2	Pcore	 Open+	AP2	core	
Resolution	range	 61-2.56	(2.62-2.56)	 110-3.40	(3.5-3.40)	 91-5.0	(5.59-5.0)	
Rmerge	 0.32	(2.564)	 0.280	(6.639)	 0.202	(3.60)	
Rmeas	 0.339	(2.708)	 0.290	(6.894)	 0.247	(4.42)	
Rpim	 0.078	(0.616)	 0.077	(1.822)	 0.138	(2.50)	
Rmerge	(top	intensity	bin)	 0.092	 0.059	 0.085	
Number	of	observations	 1277705	 688170	 74249	
Number	unique	 71252	 49558	 15525	
<(I)/sd(I)>	 8.4	(1.4)	 8.8	(0.6)	 3.6	(0.4)	
CC(1/2)	 0.996	(0.121)	 0.993	(0.176)	 0.942	(0.470)	
Completeness	%	 99.7	(99.7)	 99.9	(99.2)	 99.6	(99.5)	
Multiplicity	 17.9	(18.8)	 13.9	(13.6)	 4.8	(4.6)	
Wilson	B	(Å2)	 50.0	 100	 Refinement	
R	(Rfree)	 0.226	(0.257)	 0.205	(0.247)	 was		
RMS	bond	lengths	(Å)	 0.015	 0.011	 not	
RMS	bond	angles	(°)	 1.8	 1.7	 performed		Crystallographic	 statistics	 for	 the	 open+	 Pcore,	 closed	 Pcore,	 and	 open+	 core	structures.	
	 	
Table	S2	(related	to	Fig.	3).		
	 	 Core	(Fast)	 Core	(Slow)	 Pcore	(Fast)	 Pcore	(Slow)	PIP2	only								KD	(µM)																												Percentage																												Off	rate	(s-1)	 7.4±1.2	49%	0.067±0.018	 9.5±1.3	51%	0.0065±0.0015	 7.3±0.9	47%	0.054±0.014	 7.8±1.2	53%	0.0068±0.0019	PIP2+TGN38		KD	(µM)																													Percentage																													Off	rate	(s1)	 1.5±0.25	45%	0.038±0.006	 0.31±0.05	55%	0.00037±0.00012	 0.52±0.08	44%	0.028±0.008	 0.07±0.02	56%	0.00017±0.00007	PIP2+CD4								KD	(µM)																													Percentage																													Off	rate	(s1)	 1.5±0.3	65%	0.075±0.009	 2.6±0.5	35%	0.0018±0.0003	 1.9±0.3	61%	0.058±0.012	 1.8±0.2	39%	0.0025±0.0005		Kinetic	parameters	of	the	interactions	between	the	Pcore	or	core	and	liposomes	containing	 PtdIns4,5P2-only,	 PtdIns4,5P2	 	 and	 YxxΦ,	 and	 PtdIns4,5P2	and[ED]xxxLL	determined	by	liposome-based	SPR.		
	
	 	
Table	S4	(related	to	Fig.	6)	NMR	structure	solution	statistics	
Structural restraints  Free Protein Complex 
NOE-derived distance restraints NECAP NECAP AP2µ 
 Intraresidue 429 418 35 
 Sequential 947 963 46 
 Medium (2≤|i-j|≤4) 677 652 12 
 Long (|i-j|>4) 1448 1564 4 
 Total  3501 3597 97 
 
 Intermolecular 43 
Statistics for accepted structures 
Number of accepted structures 30 30 
 
     
Mean AMBER energy terms (kcal mol-1 ± S.D.) 
E(total)  -5530.9 ± 11.8 -6630.5 ± 11.8 
E(van der Waals) -1051.6 ± 12.4 -1155.8 ± 9.5 
E(distance restraints) 22.8 ± 2.4 39.4 ± 2.8 
 
Distance restraint viols. > 0.2Å 
(average number per structure) 2.9 ± 1.7 8.0 ± 1.8 
 
RMS deviations from the ideal geometry used within AMBER 
Bond lengths  0.0098 Å 0.0101 Å 
Bond angles  1.95° 2.05° 
 
Ramachandran statistics 
   Res. 7-131 Res. 7-131 & 152-162 
Most favoured 85.0% 78.3% 
Additionally allowed 13.7% 18.9% 
Generously allowed 0.3% 2.3% 
Disallowed  1.0% 0.5% 
 
Average atomic RMS deviations 
from the average structure (± S.D.) 
   Res. 7-131 Res. 7-131 & 152-162 
(N, Cα, C' atoms) 0.61 ± 0.14 Å 0.57 ± 0.10 Å 
(All heavy atoms) 1.05 ± 0.14 Å 0.98 ± 0.09 Å 
 	
	 	
Table	S5	(related	to	Fig.	6).			
T156-phospho	
μ2	
(149-163)	
NECAP1	
PHear	
(1-133)	
wt	
NECAP1	
PHear	
(1-133)	
wt	+	FxDxF	
NECAP1	
PHear	
(1-133)	
R102A	
NECAP1	
PHear	
(1-133)	
R32S	
n	 1.01±0.06	 1.07±0.11	 0.96±0.03	 0.93±0.03	
ΔH	(kJ/mol)	 -24.1±1.4	 -19.4±2.5	 -27.4±2.4	 -36.8±4.0	
ΔS	(J/mol*K)	 -3.09±5.05	 15.3±9.7	 -14.8±8.3	 -54.4±15.3	
Kd	(μM)	 56.4±3.1	 44.9±7.0	 57.0±1.6	 125±15			Thermodynamic	parameters	of	the	interactions	between	NECAP1	PHear	domain	variants	and	phosphorylated-µ2 linker	peptides	determined	by	ITC		
		
			
